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Abstract
The Centers for Medicare and Medicaid Services have been working with hospital
networks across the United States to improve health care through education and training
on clinical best practices and leadership frameworks. Some organizations have failed to
reach the high-quality standards of care expected and have adverse patient care outcomes.
The purpose of the study was to determine the relationship between leadership actions,
funding type, and clinical care outcomes in participating Partners for Patients hospital
programs in Iowa. The secondary variable data were provided from a Partnership for
Patients contractor, through the Centers for Medicare and Medicaid Services
Organizational Assessment Tool. Multiple linear regression analyses were used to
determine the relationship between the leadership actions, funding type, and the clinical
quality outcomes of catheter-associated urinary tract infections, central line associated
bloodstream infections, falls with injury, and venous thromboembolism. The findings
demonstrated no statistically significant relationships between leadership actions, such as
completing a leadership checklist, incident dashboard, and board involvement in decision
making, and the specified clinical care outcomes. There was a statistically significant
relationship between leadership actions of completing a root cause analysis for incidents,
federal funding type, and the clinical quality outcomes of falls with injury and venous
thromboembolism. The results of this study will be shared with Partnership for Patients
program leadership to positively impact patient care. The results may be useful as
organizations continue to implement best practices to reduce medical errors, save cost,
and increase patient safety.
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Chapter 1: Introduction to the Study
Introduction
In 2011, Centers for Medicare and Medicaid Services (CMS) launched the
Partnerships for Patients program to focus on acute healthcare system's quality care
(Centers for Medicare and Medicaid Services, n.d.). The Partnership for Patients (n.d.)
created a campaign of 26 Hospital Engagement Networks across the United States to
focus on improving care in 10 clinical care areas. The program's goal was to make
healthcare safer by producing a 40% reduction in preventable hospital-acquired
conditions and a 20% improvement in readmission care transitions (CMS, n.d.). During
the program, each Hospital Engagement Network was challenged with collecting data on
10 quality-of-care measures applicable for the hospitals and surveying leadership and
board of director engagement activities (CMS, n.d.). One of these Hospital Engagement
Networks was located in the state of Iowa and included all the hospitals across the state
(Iowa Healthcare Collaborative, 2015).
In this study, I focused on the four commonly collected clinical quality measures
among all hospitals in the state of Iowa and examined why some Iowa hospitals were
highly ranked prior to the CMS programs and continued to improve while other hospital
organizations did not improve. The four patient safety measures that I studied were the
occurrence of catheter-associated urinary tract infection (CAUTI), central line associated
bloodstream infection (CLABSI), venous thromboembolism (VTE), and injury from falls.
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Background
The Institute of Medicine (2001) described the state of healthcare in the United
States as a system that has more medical errors in organizations than are reported
publically. The current system of healthcare fails to deliver high quality of care to all that
seek the services and errors are all too common in the system that is poorly designed, illequipped to change with the technology, delivery is too complex or slow, workers are in
a shortage, and as a result the care is not safe (Institute of Medicine, 2001; Schuster,
McGlynn, & Brook, 1998). The Centers for Disease Control and Prevention (2015)
described one type of significant hospital acquired infections that can possibly be
prevented is catheter associated urinary tract infections (CAUTI). These are infections
involving the urinary systems and are associated with the prolonged use of the urinary
catheter (Center for Disease Control and Prevention, 2015).
The Centers for Disease Control and Prevention (2015) also described central line
associated bloodstream infections (CLASBI). CLASBI affect the bloodstream and are
introduced to the bloodstream as the catheter is inserted into a major blood vessel and
used during procedures, or when the area around the insertion site is cleaned (Yokoe,
et.al. 2014). Venous thromboembolism (VTE) is a clot in the bloodstream often in the
lower leg and the risk to the patient is the potential for the clot to release and travel to a
major organ such as the lung, heart, or brain (Centers for Disease Control and Prevention,
2014). The final measure included was the number of patient falls that occur in hospital
organizations. Patient falls are reported as a common determining factor for preventable
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injury, harm, and even injuries that lead to fatalities (Williams, Szekendi, & Thomas,
2014).
Leadership has been one of the contributing factors for the development of
organizational goals including the improvement of clinical quality of care (Taylor, 2012).
Aarons, Ehrhart, Farahnak, and Sklar (2014) stated that “climates should support
effective and continued evidence based practice implementation and sustainment” (p.
268). Aarons et al. (2014) and Bohan (2014) discussed the positive impact to leadership
outcomes on implementation of strategic based goals in healthcare organizations and how
some actions contributed to the success in the organization. Bohan (2014) acknowledged
that the impact of leadership on the essentials of patient care goals was missing stating
strategic alignment and clear associations between their actions and outcomes. Corley
(2015) examined improvements in hospital-associated infections (e.g., CAUTI and
CLABSI) and noted improvements in hospital-acquired conditions compared to the
reported baseline of measures; the CDC was supportive of the improvements in hospital
acquired infections from 2008 to 2013, yet did not discuss the causes for these
improvements.
Pronovost and Jha (2014) criticized the Partnership for Patients (CMS) study
design was weak, lacked transparency, and data evaluation methods made it difficult to
determine the real impact of the program for the health systems. The implication of this
article highlighted the concern from thought leaders that the Partnership for Patients
program was not cost effective and the impact of the program has been questioned
(Pronovost & Jha, 2014). In this study, there was an attempt to analyze the leadership
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activities conducted during the performance period, and could have a relationship with
the clinical quality outcomes. To date, no authored research studies have been completed
specific to the Iowa hospitals, focusing on investigating the relationship between the
occurrence of leadership activities and the CMS Partnership for Patients program
outcomes (quality of care measures).
Problem Statement
The problem addressed in this study was a lack of knowledge about whether
actions taken by hospital leadership supporting the Partnership for Patients and the
Hospital Engagement Network campaign improved patient care and quality of clinical
outcomes across the state of Iowa. This study was specifically designed to investigate
whether there was a relationship between the hospital organizational leadership actions
undertaken during the campaign and the clinical quality patient outcomes. Currently,
CMS provided organizations with more incentives, such as the Partnership for Patients
and the Hospital Engagement Network campaign, and this study was a contributing factor
to the value or benefit of the past programs (M. Nuget, personal conversation, September
23, 2016). This funding will support another three years of the Partnership for Patients
program (M. Nugent, personal conversation, September 23, 2016).
The CMS developed a public-private partnership with hospital groups across the
United States called the Partnership for Patients (Centers for Medicare and Medicaid
Services, n.d.). The Partnership for Patients program had three main elements: hospital
engagement partnership (Hospital Engagement Networks campaign), community care
transitions, and patient and family engagement. The focus of this study was to contribute
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to the work and social change that was completed over the past two years through one of
the elements of the program of the Partnership for Patients (Centers for Medicare and
Medicaid Services, n.d.), the Hospital Engagement Network. The CMS program's stated
purpose was to address the need for better quality, lower cost, and improve transparency
in the health services across the United States ("Partnership for Patients,” n.d.). The
effects of this study were categorized into three focus areas: the role of leadership, the
effect of the campaign (i.e., the impact to quality of care/services), and social change.
Purpose of the Study
Prior literature indicated that some health care thought leaders believed that the
CMS Partnership for Patients program was not cost effective that were provided and the
impact of the program has been questioned (Pronovost & Jha, 2014). In this dissertation
study, I analyzed the leadership activities conducted during the performance period and
that have a relationship with the clinical quality outcomes. Prior to this study, no studies
had specifically examined Iowa hospitals and focused on investigating the relationship
between the occurrence of leadership activities and the CMS Partnership for Patients
program outcomes (quality of care measures).
Research Question and Hypotheses
Research Question: What is the predictive relationship between hospital funding
source, the occurrence of hospital leadership activities (safety checklist, creating a
dashboard, board involved in decision making, root cause analysis), and clinical quality
outcomes (fall rates, venous thromboembolism, catheter-associated urinary tract
infections, and central line associated bloodstream infections), as measured by the

6
associated Partnership for Patients (Centers for Medicare and Medicaid Services)
criteria?


Null Hypothesis (H0): There is no statistically significant predictive relationship
between hospital funding source, the occurrence of hospital leadership activities
(safety checklist, creating a dashboard, board involved in decision making, root
cause analysis), and clinical quality outcomes (fall rates, venous
thromboembolism, catheter-associated urinary tract infections, and central line
associated bloodstream infections), as measured by the associated Partnership for
Patients (Centers for Medicare and Medicaid Services) criteria.



Alternative Hypothesis (HA): There is a statistically significant predictive
relationship between hospital funding source, the occurrence of hospital
leadership activities (safety checklist, creating a dashboard, board involved in
decision making, root cause analysis), and clinical quality outcomes (fall rates,
venous thromboembolism, catheter-associated urinary tract infections, and central
line associated bloodstream infections), as measured by the associated Partnership
for Patients (Centers for Medicare and Medicaid Services) criteria.
Theoretical Framework
The goal-path and transactional theories of leadership activities were the

underlying theory in the Partnership for Patients (CMS) leadership survey and framed
this study. The Organizational Assessment Tool (survey), conducted by the Hospital
Engagement Networks during the Partnership for Patients program, was a set of questions
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that directly related to the setting and communication of goals by leadership and the
ability for the organization to meet those goals.
Goal-Path Theory
Goal-path theory defines a leader as someone who assists employees through the
maze of complex processes to create a desired and valued outcome (Shriensheim &
Neider, 1996). Goal-path theory addressed the leader’s ability to clear obstacles in the
work setting and provided structure for the tasks and hope that it increases motivation for
the employees (Dinh et al., 2014). The goal-path (or path-goal) theory described a strong
relationship between the leader and those that they lead and this relationship often creates
a high rate of satisfaction (Shriensheim & Neider, 1996). According to House (1971),
goal-path theory stated that leadership can influence employees through having them
understanding the work and goal, the path to travel to accomplish these goals, and
reducing road blocks all by allowing the employees to gain from personal satisfaction.
This theory stated that additional strengths exist when leaders provide structure for goal
attainment to their employees and employees report positive satisfaction and demonstrate
strong performances (Shriensheim & Neider, 1996). By reducing areas where there can
be confusion and ambiguity, the negative aspects of a situation, lack of control, and
leadership dependence are reduced (House, 1971).
Goal-path theory recommends adapting to situational followers and
environmental factors (Luna, 2009). There is evidence that goal-path theory was a
foundational or contributing model for many other leadership models, including
transactional leadership. Luna (2009), Schriesheim and Neider (1996), and Schriesheim,
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et al. (2006) argued that some or all of the concepts of goal-path theory provided
foundational groundwork for later more developed models such as situational,
transactional, and transformational leadership theories.
Transactional Theory
Transactional leadership is defined as an exchange between leaders and members
that provides resources and rewards for goals (Appelbaum, Karasek, Lapointe, & Quelch,
2015). Appelbaum et al. (2015) stated that transactional leadership provides structure and
reward, managing goal completion among followers to produce highly desirable and
effective performance results in an organization. According to Melvyn et al. (2011),
transactional leadership is a style that focuses on creating an interaction or an exchange
between leader and follower to reach a common vision or mission. One of the key
elements of transactional leadership is trust in the relationship between the leader and
follower and the leaders/followers in a trust relationship will aspire to a collective
purpose and mission of change (Robinson-Hickman, 2010). This theory is consistent with
the Hospital Engagement Network continual improvement or cycle methods to drive nonvalue activities or waste out of the process (Center for Medicare and Medicaid Services,
2011).
Nature of the Study
I utilized incorporated a quantitative, nonexperimental, evaluation design with
correlational analyses of secondary data. This study design was appropriate given the
nature of the independent and dependent variables and the research question. The
independent covariables were the leadership survey responses for the questions that
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related to goal setting (checklists), communication of goals via a dashboard, goal review
and board decision making, and funding sources which were collected during the
Partnership for Patients program (Iowa Healthcare Collaborative, 2014). Also,
independent variables included the federal funding type (payment) for the hospital
organization as determined by the federal designation of Critical Access or Urban
(Department of Health and Human Services, 2014). The Iowa Healthcare Collaborative
was the contractor for the Partnership for Patients – Iowa’s Hospitals Engagement
Network and completed the leadership survey as part of the Partnership for Patients
program (Iowa Healthcare Collaborative, 2014).
The Iowa Healthcare Collaborative, during the Partnership for Patients program,
had access to each dependent variable result and data collected (Iowa Healthcare
Collaborative, 2014). Each dependent variable was a clinical quality outcomes
measurement as described by the CMS Partnership for Patients quality of care measures
(Centers for Medicare and Medicaid Services, 2014). Specifically, the dependent
variables were the outcomes of the clinical quality of care measures for fall rates, venous
thromboembolism rates, catheter-associated urinary tract infections, and central line
associated bloodstream infections.
The analysis was completed using a cross-sectional correlation design to study the
relationship of the independent variables to the dependent variables/outcomes. This study
examined the relationship between variables for data that has already been collected
(secondary survey data) through the Center for Medicare and Medicaid Partnership for
Patients program (Center for Medicare and Medicaid Services, 2011 and Iowa Healthcare
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Collaborative, 2014). I used an ex-post facto (retrospective cohort) design because the
study was after the intervention and participants were not be assigned to a certain group,
control or experimental, in alignment with Field (2013) and Walden University (2014).
The correlational statistics were used to describe the relationship between two more
variables (or scores) both independent and dependent which is the focus of the research
problem, research question(s), and population group (Field, 2013). Relationships were
determined by conducting a multiple linear regression analyses to determine the
correlation between the independent variables and each dependent variable (Field, 2013).
Definitions
The terms and phrases were used throughout the dissertation study and terms or
phrases are defined as follows:
Clinical outcome measures: The dependent variables (outcome measures) were
in an ordinal design (linear statistics) as the number of falls during the hospital stay, the
occurrence of catheter-associated urinary tract infections (CAUTI), central line associated
bloodstream infections (CLABSI), falls or venous thromboembolism rates (VTE)
associated with the practices during the inpatient stay. These measures were defined by
the CMS as clinical best practice processes for anticipated best outcomes for patient care
(Centers for Medicare and Medicaid Services, n.d., and 2011).
Demographic information: Demographic information on each participating
organization (hospital) was collected during the Partnership for Patient/Hospital
Engagement program (Iowa Healthcare Collaborative, 2014). The Iowa Healthcare
Collaborative collected the demographic information of name, date, zip code, region of
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hospital (federal designation of rural or urban), hospital type, hospital identifier (such as
National Provider Identifier – NPI; Iowa Healthcare Collaborative, 2014 and Center for
Medicare and Medicaid Services, 2011). The use of the collected demographic
information was used as an independent co-variable during the study focusing on the size
of the organization in the classification of their federally designated criteria of Urban
(including referral) or Rural (Critical Access Hospitals).
Hospital Engagement Network: The CMS developed 26 network areas across the
United States to roll out the Partnership for Patients program (Centers for Medicare and
Medicaid Services, 2011). These networks were initiated through a grant funding
program where organizations work to implement the best practice related to patient
safety, conduct training programs, provide technical assistance, track and monitor
progress as quality measurements, and identify high performing hospitals to serve as
national role models (Centers for Medicare and Medicaid Services, 2011). The focus of
this study was to contribute to the work and social change through one of the elements of
the program of the Partnership for Patients (Centers for Medicare and Medicaid Services,
n.d.), the Hospital Engagement Network.
Leadership actions and funding source: This study utilized secondary data that
had been collected prior to this study. The data type for analysis of the independent
variables was through a leadership survey (Organizational Assessment Tool) in nominal
form (questions are of yes/no design) and the funding type was categorized for size as
Critical Access, Urban, or Other. Participating hospitals in the Hospital Engagement
Networks provided information on funding type, setting goals, level of leadership
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support, and accountability through communication (Centers for Medicare and Medicaid
Services, 2011). According to Field (2013), each one of the leadership questions acted as
an independent variable and each were used in a cross-sectional analysis to its
relationship with the dependent variables (quality outcome measures). The leadership
survey reflected data on their behaviors for strategy implementation (independent
variables).
Organizational Assessment Tool (OAT): The tool that was used to collect the
independent variable is the Organizational Assessment Tool (OAT; Econometrica, 2014).
The leadership survey, OAT, was created by a Center for Medicare and Medicaid
contractor as the National Content Developer (Econometrica). The OAT, created by the
National Content Developer (Econometrica) was used by all of the national Hospital
Engagement Networks, including network in the state of Iowa (Center for Medicare and
Medicaid Services, 2011). The leadership survey was sent to all participating hospitals in
the state of Iowa during the engagement assessment by the collecting agency (Iowa
Healthcare Collaborative – Hospital Engagement Network for Iowa).
Partnership for Patients. The CMS developed a public-private partnership with
hospital groups across the United States called the Partnership for Patients (Centers for
Medicare and Medicaid Services, n.d.). The Partnership for Patients program had three
main elements, concentrating on hospital engagement partnership (Hospital Engagement
Networks campaign), community care transitions, and patient and family engagement
(Centers for Medicare and Medicaid Services, n.d.). The CMS program's purpose was to
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address the need for better quality, lower cost, and improve transparency in the health
services across the United States (Centers for Medicare and Medicaid Services, n.d.).
Publicly reported data. The outcomes of the clinical care measures (dependent
variables) were measured by publicly (hospital) reported data. Publicly reported data
were defined as data collected or submission activity completed by the hospitals, selfreported, over the CMS Partnership for Patients program period. All data were previously
collected; therefore, this study used secondary data for these organizations.
Assumptions
The assumptions of the study included decisions regarding the use of secondary
data. I decided to use secondary data that was collected during the Partnership for
Patients program because of the focus on both leadership actions and quality of services
(care) in hospital organizations. The first assumption was that there may be a relationship
between leadership actions, funding source, and quality of care or all of the data that was
collected during the program. There were limited published works regarding the
outcomes of healthcare quality and the relationship to leadership actions or payment
systems. However, part of the guidance from Partnership for Patients administration to
leadership during the program, was to continue to communicate about the quality of care
and set measurable goals for each measure.
The secondary data included all self-submitted data from the hospitals in the state
of Iowa. With the secondary data set there was an assumption that the information
provided was truthful and represented actual outcomes within the organization and no
information was falsified or omitted because of undesirable outcomes. During the data
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collection process each organization gave the authority to the Chief Executive Officer
and primary quality leader to submit data on behalf of the organization, the assumption
with the individual providing the information was that they had authority to provide the
data and the knowledge of the Partnership for Patients program measures and submission
(personal conversation, M. Nugent, March 8, 2016). There was also an assumption that
every organization supplied the entire set of variables during the data collection
procedures. Data cleaning was completed in the data analysis procedures where needed
according to sound research methods of coding missing data and removing incomplete
submissions.
Scope and Delimitation
The scope of the study was defined by the secondary data collected from the
hospital organizations and leadership in the state of Iowa. The study was designed for
analysis of hospital level data and did not include patient level identifiers or patient health
information (private health information). The secondary data were collected during the
final two year data reporting period and includes the leadership organizational assessment
results. This study did not investigate the methods in which the leadership implemented
the program; however, more concentration on leaderships’ actions to guide, sustain, or
improve the Partnership for Patients program’s outcomes. A delimitation of this study
was my decision to focus on four of the 10 quality patient care outcomes measured
during the Partnership for Patients program. I determined that four of these variables
would be applicable to my research focus while the remaining six outcome measures
would not. This was determined based on the most applicable dependent variables for all
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of the population and sample in the study. An additional delimitation was while the OAT
contains 156 individual questions, I focused on the results of the leadership action
questions as the other questions were specific to clinical care. Finally, in this study, I did
not investigate the methods in which the leadership implemented the program; rather
focused on their actions to guide, sustain, or improve the program’s outcomes.
Limitations
There were two anticipated limitations for the reliability and validity of the data
collection tool used by the primary data source and the rate of return in the independent
variable. The limitations included restricted reliability and validity testing of the OAT
(survey) prior to the use of such tool. In addition the leaders that completed the
assessment tool could have had a bias answering the questions more positively than
actually evidenced in their organization. Other limitations of the study could include the
unconscious bias for leadership actions and the impact on clinical outcomes. The studies
that have been reviewed were limited to statistical relationship or impact of leadership on
employee behaviors to the outcomes of organizational success. This study could
introduce potential bias for a relationship between leadership actions or funding source
and the improvement of clinical quality of care. Recommendations of future research
were provided following the analysis to demonstrate more direct or indirect prediction of
the variables.
Significance
One of the purposes of this study was to determine the relationship between the
program, leadership qualities, and the clinical outcomes of the patients of participating
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institutions. As hospitals continue to strive to achieve better patient outcomes, this
research can contribute to the positive social change of understanding how leadership
actions and funding relates to these outcomes. To date, there appears to be a gap in the
literature focusing on improving quality of care outcomes (measures) with specific
statistical analysis on the patients for the State of Iowa as a whole for Quality
Improvement. Others examined leadership activities for the healthcare organization and
authors stated that there may be a relationship to this value to outcomes but not
specifically to patient care (Buchner, Schreyogg & Schultz, 2014). The impact of this
study on social change was to continue to contribute to the theory of how leadership
actions and funding sources may correlate to or have a relationship on improving patient
care in hospital organization. As organizations continue to grow aware of the value of
leadership’s actions with employees it is more important to evaluate for effectiveness and
value to the patients including the value through experience with the care they received
(Goodrich & Opelka, 2015). The results of this study could be a contribution to the field
by determining how important leadership activities and funding sources are to the
possible relationship with the quality core measures. I anticipate that the results of this
study could be used to gain leadership commitment and support for leadership actions,
which focus on quality care improvement.
Summary
Over the prior years, hospitals have focused on improving the quality of care and
improvement of the services which they provide to the patient (Institute of Medicine,
2001). The hospitals in the State of Iowa have consistently performed near the top of the
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state rankings from the World Health Organizations ("State Rankings for Healthcare",
2014). The purpose of this study was to discover the relationship between these set CMS
patient quality outcomes and the hospital leadership actions and payment systems in Iowa
hospital organizations. Since seminal publications have identified that healthcare
organizations have challenges with quality of care outcomes; leadership within these
organizations continued to ask what has contributed to the quality of care (Pronovost &
Jha, 2014). The challenge exists to discover why some hospitals performed at the top of
quality rankings within the Partnership for Patients (CMS) program and was there a
predictive relationship to the payment systems and leadership actions.
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Chapter 2: Literature Review
Introduction
Several sources have estimated a large number of deaths in the United States due
to medical errors. The Agency for Healthcare Research and Quality (2015) estimated as
many as 44,000 deaths annually in the United States due to medical errors in hospital
organizations. Zineldin, Zineldin, and Vasicheva (2014) further estimated as many as
195,000 deaths annually caused by medical errors such as hospital-acquired infections
and preventable injuries. Initiatives from agencies such as the Institute for Healthcare
Improvement and Agency for Healthcare Research and Quality have attempted to create
buy-in and implementation of clinical best practice in healthcare organizations (Wang et
al., 2014; Zineldin, Zineldin, & Vasicheva, 2014). Wang et al. (2014) noted that
improvements surrounding increased efforts and a quality focus in hospitals have created
awareness across the United States for the need for better quality of care in hospitals.
Several U.S. state and local organizations have been engaged in creating a focus
on quality improvement in healthcare and have had varying success (Iowa Healthcare
Collaborative, 2011). Some areas of the country have pockets of care where the quality
exceeds the national average, such as in Iowa, where healthcare quality services are often
ranked near the top (tenth in 2014) of the Commonwealth Fund’s list for quality of care
(Radley, McCarthy, Lippa, J. Hayes, & Schoen, 2014; World Health Organizations,
2014). It was not clear prior to this study why some states, such as Iowa, have higher
clinical quality of care outcomes and if these are related to the attributes of organizational
leaders in the area of healthcare management and performance. Mah’d Alloubani,
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Almatari, and Almukhtar (2014) suggested that organization leadership could be one of
the most critical factors to an organization’s success, citing leadership actions such as
setting goals and training individuals for success as translating into improved worker
performance and organizational outcomes. This study was therefore designed to examine
the actions of leadership as a potential influence on quality of care outcomes.
The effect or implication was to address the concern from some thought leaders
that the CMS, Partnership for Patients program was not cost effective and the impact of
the program has been questioned. Pronovost and Jha (2014) stated the Partnership for
Patients (CMS) study design was weak, lacked transparency, and used data evaluation
methods that made it difficult to determine the real impact of the program on health
systems. The current state was that CMS may provide organizations with more
incentives, such as the Partnership for Patients and the Hospital Engagement Network
campaign. The problem was whether the actions taken by hospital leadership to support
the Partnership for Patients and the Hospital Engagement Network campaign had an
impact on patient care outcomes across the state of Iowa. Therefore, this study was
designed to investigate whether there is a relationship between the hospital organizational
leadership actions undertaken during the campaign and the clinical quality patient
outcomes.
Major sections of this chapter include a focus on the literature in the areas of
hospital clinical care and leadership behaviors. There are five major sections of the
chapter with subsections that continue to expand on the main section. The first main
section includes the literature introduction and problem statement with current literature
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synopsis. The second section describes the literature search strategy, which includes the
inclusion of databases and search engines, search terms, and scope of literature. The third
section includes the literature focusing on the theoretical foundation for the study,
including supporting theories, their sources, assumptions, application, rationale for the
theory, and relationship of the theories to the problems statement. The fourth section
discusses the key variables with relationship of the literature to the methods, variables,
and research question. The final section includes a summary of the literature, the final
theme in connections to the research questions, gaps in the current literature, and a
preview of the methods chapter.
Literature Search Strategy
Databases utilized included Academic Search Complete, Business Source
Complete, EBSCO Host, Med-Line with Full Text, NHS Economic Evaluation Database,
Ovid Nursing Journal Full Text, ProQuest Central and Health and Medical Complete, and
PubMed, Sage Premier. These were chosen for the topic specific needs of the study and
for the desire for scholarly peer reviewed information. Search terms that were used
included: Catheter-Associated Urinary Tract Infections (CAUTI) protocols, Centers for
Medicare and Medicaid Service and Partnership for Patients, CMS Triple Aim, Central
Line Associated Blood Stream Infections (CLABSI) protocols, clinical guidelines, falls,
goal-path leadership, healthcare outcomes and Iowa, Hospital Engagement Network,
Leadership and Outcomes Leadership Engagement, Partnership for Patients,
transactional leadership, and Venous Thromboembolism (VTE) protocols.
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The scope of the literature review includes both current literature and seminal
literature because of the needs of the study. The literature was collected from several
different periods depending on the focus and the guidelines for quality research design.
Seminal research, as defined as literature published 10 or more years’ prior, was critical
to use as background material and highlighted the topic’s impact through peer-reviewed
studies. This study was grounded in the work that others had already created a
foundational knowledge.
The current literature was considered from material that was from 2010 to 2013
and then again from 2014 to present. These years were specifically chosen because of the
problem statement and the variables for the study. Many of the 2015 articles comprise
preliminary efforts to address the identified gap in the literature concerning the effects of
the program on the clinical quality of care in hospitals across the county.
Theoretical Foundation
The theoretical bases for this study were from two leadership theories: goal-path
theory and transactional leadership theory. Goal-path leadership engaged in behavior that
rewards employee behaviors based on achievement of a goal (or behaviors) set by
leadership (Schriesheim et al., 2006). Leaders’ behavior in the transactional style can
include controlling processes, organizing the work for the employees, and short-term
planning for action plans (Howell & Avolio, 1993; Humphreys, 2005).
Goal-Path Theory
Goal-path theory was founded in the early 1970s by Evan and House
(Schriesheim et al., 2006). House (1996) stated that leadership behaviors are motivational
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when they increase the effort of the subordinate, such as coaching, guiding, and support
productive behaviors. Rewards and motivational actions can be simple things such as
comments, thank you notes, or setting a measureable goal (or actions that make up a
goal) for the department or organization, so that individuals have a strong influence in
achieving the steps (House, 1996). House (1996) also stated that increased employee
satisfaction is positively related to effective performance when the leadership behaviors
are complementary to the environment including level of authority, type of supervision,
and linkages between goals and behaviors. The leadership in these organizations should
set a goal to achieve and then work to create steps (with reward) that the individuals can
follow to the end (House, 1996).
Goal-path theory outlines how leadership can employ personal pay offs, can
clarify goals, reduce roadblocks, and increase opportunities for satisfaction. House (1971)
described goal-path theory as one in which external rewards (financial, promotions,
assignments, growth, and development) are closely linked with the goals of work and
how the work should be accomplished. House (1971) also stated that goal-path leadership
can be accomplished by when subordinates have the ability to influence the goal, exercise
control to reduce stress, and are supported through reducing barriers. Leaders who
demonstrate this theory have trait that are often more directive, supportive, involved in
the suggested actions, and participative in the decision-making. Leaders who apply goalpath theory often provide specific direction, information, and allow for easier, more
satisfying work, to be completed (House, 1971). Goal-path theory as a basic functional
approach to leadership aims to provide an environment for an employee that encourages
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them to be motivated to perform at high levels (Schriesheim & Neider, 1996). This figure
summarizes the leadership styles of goal-path theory.
Leader Style:
-Directive
-Supportive
- Participative
-Achievementorientated

Characteristics of Followers:
- Needs and - Personality
Characteristics of Situations:
- Task Structure
- Authority
- Nature of Group

Goal Achievement:
- Satisfaction
- Productivity
- Rewards

Figure 1. A diagram showing the progression outlined in House’s goal-path theory
Transactional Leadership Theory
Transactional leadership was first supported in literature in the 1940s by Max
Weber and again in the 1970s by Bass (Howell & Avolio, 1993; Humphreys, 2005).
Bass’ description of transactional leadership was one where leadership provided
something of value to the employee, rewards for performance, and provided support
(Lowe, Kroeck, & Sivasubramaniam, 1996). Other researchers have focused on
transactional leadership, which leads to transformative leadership (Howell & Avolio,
1993; Humphreys, 2005). Antonakis and House (2014) reviewed the effectiveness of the
transformational and transactional theory related to the behaviors of leadership and power
of formal authority and responsibility for the organization’s accomplishments. They
determined that there were mixed results for the relationship between actions and
outcomes and a core set of behaviors needed to be explored further.
Transactional leadership also displays a preference for risk avoidance, pays
attention to efficiency, and is similar to leadership member exchange relationship; they
pay attention to detailed and short-term goals, rules, and procedures (Bass, 1985; Craen
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& Cashman, 1975, as cited by Lowe, Kroeck, and Sivasubramaniam, 1996). The
application of transactional leadership was seen in organizations where leaders work with
the employees to define what would motivate them to achieve goals and still work within
the constraints to obtain the best possible outcome by reducing the risk. Transactional
leadership can be defined in the organization as responsive to the employee, keeps the
culture in the status-quo, create reward and punishments, and will motivate by using
employees self-interest (Bass, 1985). Leaders also use project management techniques
(standard work) to create efficient process and planning to exchange positive behaviors or
actions with personal rewards or incentives and do not make many efforts for employee
creativity and innovation for process re-design (Tyssen, Wald, & Spieth, 2012).
The negative assumption with the transactional leadership is that if used
exclusively leader can be seen as one who is motivated by position, power, personal
incentives, and trapped in politics (Antonakis & House, 2014). Overall, the themes from
the transactional leadership theory are demonstrated when leadership creates a
relationship with employees based on an exchange of the goal for the customer; this
creates support for this goal to be reached (Antonakis & House, 2014).
Relationship of Theoretical Frameworks to Study
Both goal-path and transactional leadership are the two main theories that were
utilized in this study. Creating organizational goals and providing assistance where
needed for goal achievement will be leadership behaviors questioned in the leadership
survey and are topics supported by the two theories (Shriesheim & Neider, 1996). Wong
and Cummings (2009) studied the influence of leadership behaviors on the outcomes of
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employee trust and the financial outcomes of the organization and determined that the
leadership behaviors do have an effect on the financial outcomes of the organization.
These behaviors supported the actions of the employees and created a system for which
outcomes are praised. Both leadership styles supported the outcomes of the organization
and the outcomes of improvement of clinical care are the variable in question for this
study.
One of the applications for the study was the use of goals and communication of
these goals. Goal-path was related to this study in that the leadership actions, which were
surveyed in the Partnership for Patients program closely mirrors the actions of leadership
surveyed. This setting and communication of these goals reflected in the data source
survey (OAT) to healthcare organization are reflective of the goal-path theory.
Shriesheim and Neider (1996) focused on the application of such goals in organizations
with favorable outcomes or results. There was a gap of recent literature linking the
Partnership for Patients program with the results of applications for goal-path theory. The
past application of the theory is indication of linkage to positive outcomes for
organizations with goal-path leadership.
The foundational goal-path and transactional leadership theories have been in the
literature less recently but authors have noted that these theories have been foundations
for new more modern theories (Dinh et al., 2013). Tyssen, Wald, and Speith (2013)
addressed transactional leadership in projects related to outcomes. Effective leadership
was important for ensuring the success of organizations, even in temporary programs
such as the Partnership for Patients. These authors discussed how transactional leadership
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focused on these task-orientated exchanges of action and reward of followers and leaders,
which is closely related to the leadership actions studied in this current research (Tyssen,
Wald, and Speith, 2013). Goal-path theory was closely related to Transactional theory as
they both focus on the goals or tasks and where the leader exchanges and even bargains
for necessary motivation to purse a goal. Transactional leadership provides rewards that
were found to result in positive effects for limited duration programs and specific goals
(Tyssen, Wald, & Speith, 2013).
Some authors did not support the efficacy of goal-path and transactional
leadership styles. Bohan (2014) studied the influence of leadership and the effect on
quality and safety and determined that there were limited findings in the study on the
outcomes of the organization based on the leadership style. They noted that there was
minor support for leadership to continue to have positive engagement may influence
quality and safety outcomes. This was one example that may indicate the limitation in the
effectiveness of the leadership style in relationship to the improvement of clinical quality
outcomes.
Literature Review
Healthcare organizations have been under pressures for reducing the medical
errors and activities that lead to harm since the highlighted activities in the late 1990s. In
1999 and 2001, the Institute of Medicine released two reports that focused on the need to
reduce the incidence of patient harm in hospitals across the United States (Institute of
Medicine, 2001). The Tax Relief and Healthcare Act of 2006 mandated a report from the
Office of Inspector General (OIG) on the number of events in United States healthcare
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organizations that should never happen or occur to a patient (Levinson & General, 2010).
This request also supported that there should be connection to such events and the
amount of payment related to the care during or after these events and potentially reduce
payment (Levinson & General, 2010).
In 2008, the OIG reported up to 13.5 million Medicare beneficiaries have
experience events of harm (Levinson & General, 2010). One of the measures of the report
found that hospital care following an unexpected or harmful event can estimate up to
$324 million in October 2008 or a yearly cost of $137 billion in fiscal year 2009
(Levinson & General, 2010). This type of report related to the staggering amounts of
harm and the cost associated created a federal focus on changing the healthcare system
within the United States. One of the federal supported efforts was engaging the leadership
within the healthcare organization for a change in behaviors and financial support and
partnership for change.
Organizational Leadership
Researchers who have focused on leadership styles have supported the principle
that these actions can guide and support engagement by the staff have the best outcomes
in the organization (Toussaint & Berry, 2013; Dinh, Lord, Gardner, Measure Linden, and
Hu, 2013; Birasnav, Goel, & Rastogi, 2012). Birasnav, Goel, & Rastogi (2012) found that
transactional leadership style has produced better performance in the organization if
leaders engage other in the development of goals, used different techniques to improve
knowledge in employees, and create trust. These behaviors are similar to the actions
studied in this present study. Dinh, Lord, Gardner, Measure Linden, and Hu (2013)
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discussed how each of the leadership theories have been studied for effectiveness and
emergence within the literature. Dinh et al. (2013) demonstrated positive outcomes for
the organization and they overwhelmingly supported the foundation of a performance
oriented, engaged leadership supporting the goals of the organization or program path.
Leadership is often looked to set goals and role model behaviors in organizations
and create positive cultures. Toussaint and Berry (2013) discussed the importance of
leadership guiding the organization with goals and setting the mission. They also
discussed the critical nature of transparency and communication of goals with and from
the Board. Toussaint and Berry (2013) stated that the board is critical for being
knowledgeable and supportive when organizations are face with poor outcomes. One way
to create this knowledge is communication and demonstration at meetings (Toussaint &
Berry, 2013). Both of these considered statements (leadership setting goals and the Board
involvement) were components of the leadership actions (independent variable) that are
in this proposed study. The OAT was the survey tool in the used by the data source to
record these leadership actions of goal setting and board communication (Centers for
Medicare and Medicaid Services, n.d.). This positive support for the actions of leadership
in relationship to improved quality outcomes for one organization was discussed in the
use of goal oriented leadership (Toussaint & Berry, 2013; Dinh, Lord, Gardner, Measure
Linden, and Hu, 2013; Birasnav, Goel, & Rastogi, 2012).
Researchers have focused on the relationship between leadership actions,
organizational payment, and outcomes (Buchner, Schreyogg & Schultz, 2014; Nichols &
Cottrell, 2014; Gantz, Sorenson, & Howard, 2003). Nichols and Cottrell (2014) studied
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the different traits in leadership related to the perceived desirability of the traits. They
supported that some traits, such as trustworthiness and task-focused, are more desirable
traits in high-level leadership and this desire does affect the organizational outcomes
(Nichols & Cottrell, 2014). Discussed traits were trust, intelligence, and focus on
personal success as key indicators for high performance organizational outcomes
(Nichols & Cottrell, 2014). One action that was considered is the communication of
goals. Gantz, Sorenson, and Howard (2003) supported that leadership must create a
collaborative relationship in mutual beliefs, vision, participation in planning and priority
of measure to achieve quality patient safety outcomes. Buchner, Schreyogg and Schultz
(2014) found that active board setting strategy could generally improve hospital
performance. Boards should be involved in strategy setting for hospital and collaborative
and empowerment is critical (Buchner, Schreyogg, & Schultz, 2014).
Organizational Leadership Theory
Backstrom, Ingelsson, and Wiklund (2011) suggested that the work environment
has to become more creative to make it possible to meet the demands from the customer.
DePoel, Stoker, and Van der Zee (2014) discussed the relationship between leadership
styles (transformational leadership and participative leadership) and the outcomes of the
organization (performance). This relevance exists because of the type of analysis and
study that was performed which are similar to the completed study. It is anticipated that
the methodology and methods for this study was a correlational design statistically
investigative the relationship between two or more variables. A predictive relationship
determined with a multiple linear regression analysis to determine the odds ratio and
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correlations between the variables (Field, 2013). They conducted a multilevel analysis
with both leadership styles as variables (independent variables) and a dependent variable
of organizational performance (satisfaction and commitment). This study also included a
regression analysis to test the hypotheses of how the leadership style has a positive or
negative relationship to the outcomes.
Quality in Healthcare
Over the last 20 years, healthcare organizations have attempted increase the
activities related to quality improvement and patient safety practices in the services that
are delivered (Buchner, Schreyogg, & Schultz, 2014; Classen, et.al., 2011; Cohn, 2015).
Regulators, payers, and patients are increasingly requiring healthcare organizations to
implement changes to the system to improve the safety and quality of care provided
(Øvretveit, et.al, 2011). Øvretveit, et.al (2011) studied whether contextual factors
(defined as electronic medical record or the size of the organization) influence the patient
safety practices. They did not investigate the leadership factors that may influence the
safety practices and did not find an affirmative link between their defined contextual
factors and the implementation of safety practices.
Kaplan, Brady, Dritz, Hooper, Linam, Froehle, and Margolis (2010) suggested
that there was fair association between leadership for quality, structure, implementation,
and motivation for change (goals) with quality program success. They suggested in their
findings that there was an identified weakness in the current body of literature related to
quality improvement research and how to effectively transform healthcare quality, role of
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leadership in improvement, and the development of interventions for change (Kaplan,
Brady, Dritz, Hooper, Linam, Froehle, & Margolis, 2010).
Finally, Lee et.al (2012) studied the relationship between external policies related
to payment incentives and the implementation of clinical best practices for infection rate
reduction (clinical quality best practices). They found that there was not a set of patients
that benefited from the implementation of the financial policy change (Lee, et.al, 2012).
They suggested that as the CMS “impose greater financial penalties on hospitals that
perform poorly on these (quality) measures, careful evaluation is needed to determine if
the programs work” (Lee, et.al, 2012, p.1429). For example, researchers who studied
catheter-associated bloodstream infections and catheter-associated urinary tract infections
had no evidence of measureable effects or positive outcomes based on the payment
received (Lee, et.al, 2012). These researchers have set the stage and environmental
foundation for future studies and have indicated where there is a gap in present studies.
Further efforts in the areas of relationships between leadership behaviors, payment
methods, and healthcare quality outcomes would provide valuable connection and impact
to future research for changing the healthcare environment (Lee, et.al, 2012).
Leadership and Healthcare Quality
The value of healthcare comes for patients and the assumption that the care that
they will receive is going to be safe, timely, appropriate, and error free (Schyve, 2009).
The Joint Commission for Hospital Accreditation, one of two organizations who survey
and accredit healthcare organizations for quality, address the importance of leadership
with quality stated that organizational leadership is critical to organizational success and
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they must work together to achieve the organizational goals (Schyve, 2009). The Joint
Commission has supported the idea of leadership and governance responsibilities for the
mission of healthcare organizations and has employed measures to ensure a culture. They
stated that “culture that fosters safety and quality, planning and provision of service that
meets the needs of the patients, availability of resources for providing care, sufficient
number of competent staff and other care providers, and ongoing evaluation and
improvement of performance” (Schyve, 2009, p. 3).
Toussaint and Berry (2013) stated that value for the healthcare patient is defined
as the quality of the services divided by the cost of the services. The mission of many
healthcare organization leaders have been attempting to drive healthcare quality to meet
the standard of best practices and challenged to drive out the cost because of decreasing
reimbursements (Toussaint & Berry, 2013). Standard practices in healthcare
organizations, including the leadership behaviors, should continue to drive the work
practices to learn what is contributing to the best outcomes within the organization and
then deploy this standard across the organization.
The implementations of these practices have been slower than most expected
from the Institute of Medicine report (Hayes, Batalden, & Goldmann, 2015). A further
level of quality cannot be achieved by just continuing to stress the current system and
expect different outcomes; leaders must also respond in their behaviors and the methods
in which they lead (Hayes, Batalden, & Goldmann, 2015). Employees of healthcare
organizations have been asked to continually implement new standards focusing on
quality and evidenced-based practices, such as healthcare acquired infections, to prevent
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errors, and all of these guidelines to make healthcare safer has actually made the work
much harder (Hayes, Batalden, & Goldmann, 2015). Hayes, Batalden, and Goldmann
(2015) recommended that leaders need to take “a more careful assessment of the task and
processes associated with the change initiatives, the time and resources needed to plan
and effectively implement any of the added work assignments” (p. 101). Toussaint and
Berry (2013) stressed that these standard leadership behaviors, such as goal setting,
communication and deployment of quality mission, drove the understanding and common
practice for the employees of the organization resulting in better quality of care
outcomes.
Leadership has been defined as the behaviors and traits that a person demonstrates
to create a relationship or actions. The leadership behaviors have been studied in
relationship to such behaviors and leadership (Baysak and Yener, 2015). Baysak and
Yener (2015) studied the relationship between leadership behaviors and stress levels due
to goal attainment. They found that leadership style does have an effect on the outcomes
of the organization, specifically their support and reduction of stress due to external
regulations and pressures. Leaders can use influence of their words to create motivation
and actions. Policy leaders are often the leaders that set these external pressures due to
the nature of the patient safety efforts (Baysak and Yener, 2015). Leadership with strong
values, assumption, belief and expectations about their environment can establish clear
goals and work procedures for employee contributions. The opportunity for this study is
to explore if these leadership behaviors have a positive or negative relationship on the
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outcomes of the organization. I did not focus on the specific ideals or values; however, I
studied the behaviors related to influence and motivation for the patient safety goals.
Programs that Support Quality
There have been other national campaigns that have supported the quality of care
practices but the Partnership for Patients campaign was the first to implement changes
related to all healthcare stakeholders including the healthcare organizations and payment
systems (Centers for Medicare and Medicaid Services, 2014). By changing the influence
on all parties to change in the same direction the campaign was held to the goals of
having a 40% reduction in hospital-acquired conditions and other preventable conditions
(Centers for Medicare and Medicaid Services, 2014). With the campaign came three
major components of the Centers for Medicare and Medicaid Innovation Center including
the financial investment for implementation of best clinical practices, federal partnership
alignment, and as many outside partnerships as possible (Centers for Medicare and
Medicaid Services, 2014).
The efforts of such a national focus are supported by studies conducted by
organizations such as the Office of the Inspector General (OIG) that provide evidence
that 13% of hospitalized Medicare beneficiaries experience an adverse (unexpected
outcome or harm) event (Levinson & General, 2010). As a results of this comprehensive
effort, 80% of the hospitals across the United States committed to reporting 11 different
quality of care measures, funded through the Hospital Engagement Networks during 2012
to 2014 (Centers for Medicare and Medicaid Services, 2014).
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Government policy actions, such as the Partnership for Patients, have focused on
making hospital care safer, more reliable and less costly and did so by engaging leader
ship in the quality improvement activities in their organization (Centers for Medicare and
Medicaid Services, n.d.). Researchers for healthcare quality improvement programs,
including the impact of the Partnership for Patients, questioned implementation of the
clinical best practice, leadership activities, and payment mechanisms for healthcare
organizations (Pronovost & Jha, 2014). They stated that the Partnership for Patients
participants did not have complete pre and post measurements that were consistently
defined, they questioned the design (randomization and control groups), measures, and
validity of the initial studies with the program (Pronovost & Jha, 2014). Pronovost and
Jha (2014) suggested that given the amount of money spent and the hours dedicated to
the quality improvement program, the current literature and study has failed to support
the relationship between the outcome of the Partnership for Patients program and the
sustainable results in healthcare quality. In contrast, researchers have found that
leadership behaviors or actions do have an impact on the outcomes or results of
organizations (Luna, 2009; Melvyn, Hamstra, Yperen, Wisse, and Sassenberg, 2011).
In 2014, CMS produced a summary of finding that supported the activity and
support of the Partnership for Patients (Centers for Medicare and Medicaid, 2014). The
authors discussed that even with the focus areas of patient harm one of the critical factors
to the hospitals success was the engagement of leadership with the Partnership for
Patients improvement measures and the amount of support for data (outcome) measures
submitted (Centers for Medicare and Medicaid, 2014). The Centers for Medicare and
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Medicaid Services (2014) report on the benefits of the Partnership for Patients strong
inference to positive results were inconsistently presented in the report as stated
Since hospital payment policies and other U.S. Department of Health and Human
Services program that played an important role as part of the Partnership for
Patients campaign were in place and making change over time, it is not possible at
this time for the evaluation to identify the portion of these harm reduction and
saving... (p. 2).
However, there is a present gap in the literature which supports the involvement of
leadership in quality improvement program, connections to the relationship between the
leadership behaviors surveyed and the clinical care outcomes related to the guidance of
the Partnership for Patients program.
Independent Variables for Study
One of the two sets of independent variables for this study included the leadership
actions surveyed in the healthcare organizations through the OAT. Authors have
addressed the effectiveness of the transaction type leadership, including Antonakis and
House (2013). My study addressed the instrumentation to determine leadership style;
however, Antonakis and House (2013) addressed some points that are critical for this
study. Antonakis and House (2013) discussed that management should continue to
improve their actions and the style of leadership does have a positive effect when
guidance is task orientated, with simple feedback and coaching. These behaviors were
similar to the behaviors surveyed in this study.
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Another independent variable is the federal funding type or payment system for
each of the organizations involved in the study. In the state of Iowa, hospitals funding
type happen to be in one of three types of systems. The first two types, Prospective
Payment System (PPS) and Rural Referral, are actually funded in the same manner where
they are paid based off of predetermined rate adjustments for quality (Department of
Health and Human Services, 2013). For the focus of this study these two types of
organizations were considered “Urban”. The other type of payment system or
organization category for this study was considered Rural, or commonly called Critical
Access Hospital (CAH; Department of Health and Human Services, 2013). There are
specific criteria to be certified as a CAH including rural location, primary and emergent
services, have less than 25 inpatient beds, low length of stay for acute illnesses, and
located in a state that has a rural health plan (Department of Health and Human Services,
2013). Medicare and Medicaid payments for CAH are not subject to the same payment
type as urban facilities and CAH are paid for inpatient and outpatient service at 101
percent of reasonable costs (Department of Health and Human Services, n.d.). In the state
of Iowa there are 118 hospitals, of which 86 are CAH, and for the Partnership for Patients
program all hospitals (urban and CAH) did committed to participate in 2011 (Iowa
Healthcare Collaborative, 2014).
Cohn (2015) reported that data that was collected by the Department of Health
and Human Services (CMS) since 2010, demonstrated that the 2014 figures a decreased
rate of hospital-acquired conditions by 17% and bloodstream infections fell by 50%
linked to the implementation of the clinical best practices supported in the Partnership for
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Patients. Pronovost and Jha (2014) continued to challenge if the Partnership for Patients
program did improve the quality of care. They questioned the Partnership for Patients
program for the amount of money invested as the clinical measures were still being
developed with the problems still continuing to exist in 2014. This also suggests for my
study that the outcomes of the clinical quality of care measures (Partnership for Patients
program) are provided as clinical guidelines or recommendations. My study did not
investigate the approach used to apply the measure and may indeed be limited or
benefited by the organization’s application of the measures or the ability to successfully
integrate the best practice into clinical care. These results continued to be reviewed and
studied for more impressions on the impact of the program.
Dependent Variables for Study
The rates of medical errors or adverse events for healthcare organizations were
the operation definition of the dependent variable for this study. The impact quality
improvement activities on the clinical quality of care were used for the dependent
variable in this study. Literature related to the hospitals quality outcomes have been
addressed since 1999 when the Institute of Medicine (2001) presented To Error is Human
which underscored the need for improvement in the US healthcare system (Agency for
Healthcare Research and quality, 2013). Ouslander and Shutes (2015) stated the CMS
“Triple Aim” and Partnership for Patients had goals of reducing hospital readmission and
hospital-acquired conditions, such as infections and harm, resulting in reduced
complication, morbidity, mortality and healthcare cost of up to and estimated billions of
dollars over the next few years.
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The Centers for Medicare and Medicaid Services (2010) determined that best
clinical quality of care and the methods for the organizations to implement effective, safe
and high quality of care were published as Clinical Best Practice protocols with the goal
of changing medical practices and healthcare organizations. Reflected in this study were
the clinical outcomes, or the dependent variables, produced by healthcare organization
across the state, specifically during the Partnership for Patients program years of 2012 to
2014 (Centers for Medicare and Medicaid Services, 2014). Stated that if the clinical best
practices guided and provided by the Centers for Disease Control and Prevention
hospitals could provide safer, higher quality of care, these would create a system for
preventing may hospital acquired injuries and possibly patient fatalities (Centers for
Medicare and Medicaid Services, 2010).
The dependent variable is further defined by the outcomes of clinical practice for
patients in healthcare organizations and in study’s authors have discussed the urgency or
need for such an improvement program. Levinson and General (2010) discussed how
current healthcare organizations are still studying the improvement methodologies which
may have a relationship to or support clinical best practice. They stated that 13% of
Medicare patients suffer an adverse event while hospitalized and an additional 13%
suffered an event that caused harm. This supports the theory that organization that focus
on improvement methods, including implementation of clinical best practices,
demonstrate improvement in outcomes. Other researchers have determined that there are
a few best practices that could lay a foundation for better health outcomes. Chilingerian
(1995) determined the top 36 clinical best practices for acute hospitals systems to
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implement in order to reduce the cost of medical care and ultimately provide the highest
level of care possible for the patients. These researchers have supported that the
Partnership for Patients program has foundational support for the focus areas of
improving clinical quality of care.
There are four specific best practices defined in the dependent variable. These
clinical areas were falls, patient hospital acquired infections from urinary and
bloodstream catheters, and venous thromboembolism (Centers for Medicare and
Medicaid Services, 2014). Chilingerian and Sherman (2011) published best practices
including the prevention of hospital associated infections (CAUTI and CLABSI), venous
thromboembolism, and patient falls. They explained what was expected in the
implementation of clinical best practice. Everhart, Schumacher, Ducan, Hall, Neff, and
Short (2014) focused on specific implementation of clinical best practices such as
investigated determinates or indicators of fall rates in patients who were suffering from
acute illness. They found that hospitals with lower fall rates demonstrated more evidence
of clinical best practice implementation. Additionally supporting the implementation of
these clinical best practice guidelines as reported in the dependent variable in this study.
Most of the clinical best practices are not manually reported in the hospital
organizations. Garrido, Kumar, Lekas, Lindberg, Kadiyala, Whippy, Crawford, and
Weissberg (2014) discussed how the dependent variables, such as Venous
Thromboembolism, are collected in these organizations through organizations electronic
health records. Most organizations do not have fully automated reporting for these data
yet most of the information is stored in the electronic health record and must be manual
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abstracted (Garrido et al., 2014) Garrido et al. (2014) reported that this lack of
automation created an inefficient step to the work, creating the possibility that care may
not be accurately reported. This could create a study limitation to fully study the
relationship of action on the dependent variable.
Summary and Conclusions
Quality improvement in the healthcare organizations continues to be a focus of
both private initiatives and federal regulations and initiatives. Ryan and Mushlin (2014)
discussed that the full effects of the Accountable Care Act and the full effect on patient
care, safer organizations, and cost reductions are still to be determined. This study
focused on the quality outcomes in healthcare organizations across Iowa and the
relationship to the federal funding sources and leadership activities. The World Health
Organization (2014) provided a listing of states and the analysis of their quality of care
based on quality, satisfaction, patient safety, and cost of care. The state of Iowa continues
to rank at the top in the areas of quality and safety. This aspect of the quality
improvement efforts of organizations was examined for influence on the outcomes by
comparing the healthcare outcomes/result to the federally designated funding and
leadership actions.
Ryan, Harris, Mattox, Singh, Camp, and Shirey (2015) had two major themes that
were critical for the study. After 15 years from the report from the Institute for Medicine
(2001) stated that healthcare is still struggling to improve outcomes and control costs
(Ryan, Harris, Mattox, Singh, Camp, & Shirey, 2015). Lack of implementation,
dissemination, quality improvement standardization and buy-in strategies may have been
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factors in the lack of effectiveness (Ryan, Harris, Mattox, Singh, Camp, & Shirey 2015).
These challenged factors were all potentially overcome in the Partnership for Patients
program from 2012 to 2014. Their literature review and analysis completed for years of
2009 to 2014, presented themes and supported leaders’ communication of clear goals and
significance of the change. These actions are imbedded characteristics of leadership as
the transformational theory presented (Ryan et al., 2015). These statements continue to
support the proposed independent variable. This contextual background of this literature
justifies the rational for the independent and dependent variables and provides a prior
approach to the analysis of a similar problem statement to the proposed research.
There was a gap in literature, qualitative and quantitative analyses for the
Partnership for Patients program. As Pronovost and Jha (2014) questioned the efficacy of
the Partnership for Patients program and the amount of impact that the program may have
had on the healthcare delivery system is still yet to be discovered. To date there was
significant gap in literature investigating the different states or groups that participated in
the Partnership for Patients program and the quantitative analysis of the outcomes. There
was no literature discussing the impact of the program in the State of Iowa. The literature
that was present was used to address the operational definition of the variables within the
study or set a foundation for the study to discover the relationship between these
variables within the program. The discovery of such an influence, continued to address
the gap in literature regarding the impact, relationship, and even the key components to
practice implementation.
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Literature theory supported the groundwork of leadership action to organizational
outcomes; yet, missing was the link to clinical quality outcomes in healthcare. Methods
demonstrated my focus on relating these leadership actions to the clinical care outcomes
or results, which overall address the goals of improving healthcare outcomes or quality.
Studying the relationship provided one more link between the theory of organizational
leadership and the actions impact on organization performance outcomes. The results of
this study continued to support the Triple Aim of healthcare to increase value, decrease
the cost, and improve the quality.
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Chapter 3: Methodology
Introduction
In 1999 and 2001, the Institute of Medicine released two reports that focused on
the need for reduction in patient harm in hospitals across the United States (Agency for
Healthcare Research and Quality, 2013). These created awareness surrounding the need
for better quality of care in U.S. hospitals and resulted in initiatives from agencies such as
the Institute for Healthcare Improvement and Agency for Healthcare Research and
Quality (Agency for Healthcare Research and Quality, 2015). The Partnership for
Patients program was created to create a focus on the reduction of medical errors and
deaths related to preventable medical defects (Agency for Healthcare Research and
Quality, 2015), and due to the success of the programs the program has continued to be
funded in 2015 and 2016 (M. Nuget, personal conversation, September 30, 2016). These
initiatives were put in place to attempt to create buy-in and implementation of clinical
best practice in healthcare organizations (Wang et al., 2014; Zineldin, Zineldin, &
Vasicheva, 2014). The purpose of this study was to investigate potential relationships
between leadership behaviors and clinical quality of care outcomes by analyzing the
relationship between the quality of care, in the State of Iowa, and the leadership actions,
considering the hospitals funding designations.
This study required a specific research design and rationale for sound analysis of
secondary data. These following sections include the study’s variables, research design
and rationale, methodology, validity threats including ethical concerns, and summary.
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These sections allowed for sound design to produce quality study research methods and
results.
Research Design and Rationale
Variables
The independent variables for this study were five questions from the
Organizational Assessment Tool (OAT) from the Partnership for Patients program
(Econometria, 2013). The first four independent variables were survey questions that
elated to the leadership actions focused on the guiding the organization during the
Partnership for Patients program period. The complete set of questions from the OAT can
be found in the Appendix A and are defined later in the chapter. The fifth independent
variable was the hospital payment designation from the U.S. federal government.
Iowa has two main reimbursement or hospital funding types in the state. The first
is Prospective Payment System (PPS), which is a fixed payment model from Centers for
Medicare and Medicaid Services (CMS) and other insurance organizations for a patient’s
acquired charges no matter the severity or cost to the hospital (CMS, 2015). The second
designation for Iowa hospitals is Critical Access Hospital (CAH), which are at or below
24 beds in size and have a payment model of cost of services plus one percent
(Department of Health and Human Services, 2014). The dependent variables were four
patient safety, or clinical care measures, in which data were collected for the occurrence
of these outcomes during the Partnership for Patients program (CMS, n.d.). The
independent and dependent variables for the study included the measures stated in Table
1. These variables were defined as preventable harm to patients during a hospital stay and
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the goal of the Partnership for Patients program was to reduce these occurrences to zero
(CMS, n.d.).
Table 1
Independent and Dependent Variables and Codes
Variable
Independent Variables
Hospital Payment
Leadership uses safety Checklist at meetings
Leadership creates a safety Dashboard for goals
Leadership involves the Board in safety Decision Making
Leadership determines Root Cause was due to communication
Dependent Variables
Catheter-Associated Urinary Tract Infection
Central Line-Associated Blood Stream Infections
Injuries and falls from immobility
Venous Thromboembolism

Code
Payment
Checklist
Dashboard
Decisions
RCA
CAUTI
CLABSI
Falls
VTE

Research Design
The research approach was a quantitative study with a nonexperimental
evaluation design and correlational analyses conducted utilizing secondary data. I
specifically analyzed cross-sectional data to determine the relationships between the
independent and dependent variables. This type of research design is commonly used to
investigate the relationship between variables for data that has already been collected
(secondary survey data) (Field, 2013). The data were secondary data provided by the
Iowa Healthcare Collaborative, as they were the data collection contractor for the
Partnership for Patients program (Iowa Healthcare Collaborative, 2014). The analysis of
the data resulted in an improved understanding of the relationship between Iowa Hospital
leaders’ actions, federal funding designation, and healthcare outcomes.
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The purpose of a quantitative correlational research design was to seek
determination if the independent variable is related to the dependent variable(s) but
cannot establish causation (Brink & Wood, 1997). This study design was chosen because
of the nature of the independent and dependent variables and the research questions.
The use of the design can be called ex-post facto (quasi-experimental) because the
study was also after the intervention (ex-post facto) and participants were not be assigned
to a certain group--control or experimental (Field, 2013). For the purpose of this study,
the population was not split into a control group because the relationship between
funding type (payment system) and the dependent variables can be studied. The
correlational design used to determine the relationship between two more variables (or
scores) both independent and dependent variables was the focus of the research problem,
research question(s), and population group, in alignment with Field (2013). By using this
type of study, it was possible to conduct statistical analyses to calculate relationship
between the variables (leadership behaviors, hospital payment and clinical quality
outcomes) and relates these variables to a hypothesis for study. This research design
allowed for the study to continue addressing the needed quality improvements in
healthcare organizations across Iowa and employed statistical procedures to measure a
theory (leadership theory).
Other quantitative research designs, such as a descriptive (case study), semiexperimental or experimental (which provide a quantitative or numeric description of
attitudes or opinions) were not applicable because of the population and the use of
secondary data in a nonexperimental design. A pre-/post-experimental design was not
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appropriate because the hypothesis did not call for the investigation or change of the
variables over time or before and after the Partnership for Patients program. For example,
in an experimental design, the population may need to have a control group for the study.
In this case, the population remained as one group so as to study the relationship of the
payment system and the clinical quality outcomes (dependent variables).
There were no anticipated time or resource constraints in the study’s data retrieval
or effects on design methodology. The study used secondary data that has been collected
prior to this study by the data source. The design included a nonexperimental use of
secondary dataset; therefore, the time and resources required to recruit, participate, and
collect that were not applicable. The data source was prepared to support the study with
data sharing and took limited resources (time) on the behalf of the data provider. The data
provider had already signed a data use agreement, reducing the time constraints for
approvals.
The use of a quantitative, nonexperimental design was determined because of the
research question, the type of variables, and the use of secondary data. It would not be
ethical to conduct a true experimental design to limit or restrict care provided to a patient
in an acute care organization (Frankfort-Nachmias & Nachmias, 2008). Variables were
collected as they occurred, post program implementation (intervention), and studied to
determine if there was a strong or weak relationship between these disparate variables.
Methodology
Methodology section covered the population, sampling, procedures, and data
collection processes for the completed study.
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Population
The target population for this study consisted of the acute care hospitals in the
State of Iowa. The current number of hospital organizations is 118 and all organizations
were included in this study. The study could have a finite population; however, the
outcomes may lead to behaviors that could transfer other management, potentially
assisting in the measureable success of the organization. The potential size of the study
was a purposeful convenience sample and was able to reach all of the hospitals. All
hospitals that reported were included; however, if a feasible sample size with an
acceptable standard error and the selection of the size of the sample was based on a
probability sample design (Frankfort-Nachmias and Nachmias, 2008). This population
and size was feasible because of the current relationship with the hospitals thought the
Iowa Healthcare Collaborative and the Iowa Association for Hospitals, which allowed the
access to the data. It is also assumed that the sampling of the population continued to
represent all hospitals of the United States. In general, the 118 hospitals of the state of
Iowa are consistent in size, scope, and services with the entire population of U.S.
hospitals.
Sampling & Sample Procedures
Sampling strategy. The sampling strategy for this study was a purposeful
convenience sample. A purposeful convenience sample is a study in which the
participants are not selected based on any sort of predetermined variables, the participants
are easy to access, and are available because of geographic location (Frankfort-Nachmias
and Nachmias, 2008). This sampling strategy seemed to be within the cost, time, and
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manageable limits. The largest factor for the hospital in the state of Iowa to be selected
was the convenience of location and the ability to access these organizations from the
researcher's fund and location. Based on the power analysis, I attempted for a minimum
sample of 88 hospitals that are currently serving the residents of Iowa in the rural settings
defined as the critical access hospitals. This sample was based on the power analysis to
produce a minimum, yet the study did use all useable data in the secondary database from
the instrumentation.
Other sampling techniques that were considered included quota samples and
probability sample designs. Quota samples could be used with a sample that as similar to
the large populations (Frankfort-Nachmias and Nachmias, 2008). In this study, the
population was the entire hospitals within the state of Iowa, and the sample was nearly
the entire population versus, in a quota sample, the population would be much larger.
Probability sample designs, such as random samples and stratified samples, are used with
the samples need or have the likelihood to represent the entire population (FrankfortNachmias & Nachmias, 2008). Again, this study used the entire set of Iowa hospitals as
the population and a sampling was not needed for representation
Power calculations. According to Burkholder (2012), there are three different
sampling calculations that need to be completed for the sample size of a multiple
regression. First, Statistical Power and the accepted value for the power or probability
was .80 (80%) (Buchner, Faul, & Erdfelder, n.d.; Burkholder, 2012). The second is
Alpha, and the standard practice is .05 for most psychological research (Burkholder,
2012). However, Trochim, Donnelly, and Arora (2016) stated that for a more rigorous
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test the calculation of .01 alpha (statistical significance) should be used for calculations.
The third factor for calculations is the effect size or calculation of Cohen's d, which
studies the difference between the two groups, and preferred to be between .50 and .80
(Burkholder, 2012). Burkholder (2012) also stated that where there is very limited
research, for example the leadership behavior and the relationship to clinical outcome
comparisons, research should follow the average of the Cohen's d of .65. By using the
tables for Required Sample Size (Research Advisors, 2006) with a power of .80 (alpha =
.50) and an average effect size of .65 the sample size would be 24 of the hospitals in the
sample size. By using the G-Power Analysis of Buchner, Faul, and Erdfelder (n.d.), the
calculations demonstrated a power of .80, alpha of .01, and effect size at .15 (or 85%) the
total necessary sample size was calculated to 88 participating hospitals. This study
continued to strive for the sample size of the 88 hospitals from the state of Iowa for the
more rigorous testing.
Procedures for Archival/Secondary Data
Recruitment procedures. All of the Iowa hospitals have been participating in the
CMS Partnership for Patients (n.d.) data collection effort for over two years and reporting
information to the Iowa Healthcare Collaborative or national publicly reported entities
(Iowa Healthcare Collaborative, 2014). The Iowa Healthcare Collaborative had been
collecting information for the Partnership for Patients program since 2012 with the goal
of continuing to review and analyze the data for driving performance in the state of Iowa.
Participation procedures. For the last two years, measurements for this study
have been collected over the course of the Iowa Partnership for Patients program, called
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the Iowa Hospital Engagement Network (Iowa Healthcare Collaborative, 2014). The
Iowa Healthcare Collaborative was the contractor for the Partnership for Patients, Iowa’s
Hospitals Engagement Network and completed the leadership survey as part of the
Partnership for Patients program (Iowa Healthcare Collaborative, 2014) and hospitals
have had the option to submit data for clinical quality measures. Independent co-variables
include the funding type for the hospital organization as determined by the federal
designation of Critical Access or Urban (Department of Health and Human Services,
2014).
During the Partnership for Patients program the Iowa Healthcare Collaborative
organization collected independent variable data from Hospitals across the state of Iowa
with the leadership survey, OAT, instrument in nominal form (questions are of Nominal
or Ordinal design) and the funding type was be categorized for size as Critical Access or
Urban (See Table 2). The leadership survey, OAT, which was created by a Center for
Medicare and Medicaid contractor as the National Content Developer (Econometrica) for
the purposes of assessing participating hospitals in the Hospital Engagement Networks, in
the area of setting goals, level of leadership support, and accountability through
communication (Centers for Medicare and Medicaid Services, 2011).
The clinical quality outcomes (dependent variables) as described by the CMS
Partnership for Patients quality of care measures were also collected over the program
from 2012 to 2014 (Centers for Medicare and Medicaid Services, 2014). Part of the
Partnership for Patients program was to complete an agreement document with each of
the participating hospitals involved in the Hospital Engagement Network, which agreed
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that the data would remain confidential, as the organizations where asked to submit the
results of the leadership survey at the beginning of the program and then on-going
clinical quality outcome results.
Data collection. The research question for this study was to investigate the
predictive relationship between hospital funding source, the occurrence of hospital
leadership activities (public commitment, setting organizational quality goals, and goal
review), and clinical quality outcomes (defined prior) as measured by the associated
Partnership for Patients (Centers for Medicare and Medicaid Services) criteria. The
hypothesis was that there is no (null) or is a (alternative) statistically significant
predictive relationship between hospital funding source, the occurrence of hospital
leadership activities (public commitment, setting organizational quality goals, and goal
review), and clinical quality outcomes.
Most of the secondary was used in this study was originally collected by the Iowa
Healthcare Collaborative for the Hospital Engagement Network’s Partnership for Patients
program (Centers for Medicare and Medicaid Services, n.d.; Iowa Healthcare
Collaborative, 2014). The leadership survey was sent via email to all participating
hospitals in the state of Iowa during the engagement assessment by the Iowa Healthcare
Collaborative, the collecting agency, prior to my study beginning of the Hospital
Engagement Network for Iowa starting in 2014 (Iowa Healthcare Collaborative, 2015).
The use of the collected demographic information was used as independent
variables including the size of the organization in the classification of their federally
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designated criteria of Urban (including referral) or Rural (Critical Access Hospitals). The
dependent variables (outcome measures) were in an ordinal design (linear statistics) as:


Venous Thromboembolism rates (VTE) associated with the practices during the
inpatient stay,



the number of Falls with injury,



the occurrence of Catheter-Associated Urinary Tract Infections (CAUTI), or



the occurrence of Central Line Associated Blood Stream Infections (CLABSI).

The outcomes of the clinical care measures (dependent variables) were gathered from
different sources:


Venous Thromboembolism (VTE) – publicly, hospital-reported data;



Falls data – either the Iowa State Inpatient Database (SID; data source) or national
contract databases; and



Catheter Associated Urinary Tract Infections (CAUTI) and Central Lineassociated Bloodstream Infection CLABSI – the Centers for Disease Control –
National Healthcare Safety Network (CDC-NHSN).

Publicly reported data, in the context of this study were defined as data collected or
submission activity completed by the hospitals, self-reported, over the CMS Partnership
for Patients program period. All data collected were previously completed; therefore, this
study used secondary data for these organizations.
Permissions for access. Access to this secondary data set was granted by
permission from the leadership of the Iowa Healthcare Collaborative organization (data
source). This permission to use the data were granted in written from and be
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accompanied by a written contract between researcher and the data source. Appendix B
and Appendix C contains the contractual letter and agreements for data and material use.
According to the appropriate timeline the data set was sent, via secure data transfer of
encrypted email, from the data source. The data were collected at the individual hospital
level; however, the hospital’s identification information was de-identified. Identifiable
information for the hospital would include name, address, personnel names, or other tax/
identification numbers. Data reports contained de-identified organization name via code,
indication of urban or critical access funding source, leadership survey results, and
nominal results from the last report of clinical care outcomes.
Reputability of sources. This source of secondary was the only and most
reputable data source because of the nature of the data and the only organization that
would have access to the retrospective leadership assessment related to the Partnership
for Patients program. The data source was selected to complete such data collection of
both independent and dependent variables through a rigorous selection process for the
Hospital Engagement Network by the Centers for Medicare and Medicaid Services
(2011). Data for the study remained de-identified throughout the study with only a unique
identifier for each of the hospital organizations. There was an assigned code for the
independent variables and dependent variables.
The Iowa Healthcare Collaborative is a nongovernmental contract for the
Partnership for Patients program; however, they have had a relationship with the
healthcare community in Iowa since 2006 when it was created with the mission to drive
the quality of healthcare across the state. The Iowa Healthcare Collaborative has
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implemented and tested several other national quality initiatives including the Institute
for Healthcare Improvement (Iowa Healthcare Collaborative, 2011). The Iowa Healthcare
Collaborative had been collecting quality of care measures or outcomes through these
national programs since 2006, reporting measurements, and a mission to improve the
healthcare across Iowa. The independent variables, including the funding type for the
hospital organizations, were determined by the federal designation of Critical Access or
Urban (Department of Health and Human Services, 2014). This variable be indicated in
the data source provided by the Iowa Healthcare Collaborative with the type of Federal
funding source indicated as either urban (prospective payment system) or critical access
(fee-for-service).
Instrumentation
Organizational Assessment Tool. The leadership survey, OAT, was created by a
Center for Medicare and Medicaid contractor as the National Content Developer
(Econometrica) for the purposes of assessing participating hospitals in the Hospital
Engagement Networks, in the area of setting goals, level of leadership support, and
accountability through communication (Centers for Medicare and Medicaid Services,
2011). The data type for analysis of the independent variables was through this leadership
survey, OAT, instrument in nominal form (questions are of yes/no design) and the
funding type was categorized for size as Critical Access Hospital or Urban (see Appendix
A). The leadership survey was sent to all participating hospitals in the State of Iowa
during the engagement assessment by the collecting agency (Iowa Healthcare
Collaborative – Hospital Engagement Network for Iowa). According to Field (2013) each

57
one of the leadership questions act as an independent variable and each used in a crosssectional analysis to its relationship with the dependent variables (quality outcome
measures). The leadership survey reflected data on their behaviors for strategy
implementation (independent variables).
The OAT did have some potential instrumentation biases. It was created for the
CMS use during the Partnership for Patients program and was specifically designed with
the leadership initiatives that the organizations were encouraged to implement in their
organization. The assessment tool was not a published peer reviewed tool, yet it was
created by the research center for purposes of the program (Econometrica, 2013). There
is limited evidence for creation of the OAT with the reliability testing and instrument
validity.
Reliability testing information was not able to be obtained from Econometrica. It
was not possible to obtain the testing information, specifically reliability and validity
testing from the content creator, Econometrica, due to contract relationships with the
CMS (M. Sheppard, personal conversation, February 19, 2016). According to
Econometrica director this information was not released to the Partnership for Patients
contractors or the public, it was only released to CMS in their final report (M. Sheppard,
personal conversation, February 19, 2016). Due to this limitation in publicly reported
information, data in this study, the OAT survey, was subject to testing for internal
consistency (reliability). This was determined because of the lack of evidence from the
creator of the tools for the survey development used during the data collection a
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Cronbach’s alpha test was conducted on the questions from the OAT that was used in this
study.
Other control methods would have increased the strength of the study and
decreased the limitations of the study, such as asking for other influential leadership
behaviors (content validity), running a control group to determine the predicted results
(empirical validity), and comparing to the framework of other validated leadership
theories (construct validity). The strongest of these validity measures is the construct
validity because the leadership theories have been seen as foundational behaviors through
many other studies. By asking for open-ended questions at the end of the survey this may
have determined some of characteristics of leadership that would influence the behaviors.
However, this challenges the study to determine the themes and quantify the subjective
information.
Operationalization
The independent variables for the study included five questions from the OAT.
The independent variables were either the federal payment designation or the four
questions that relate to the organization’s leadership actions related to the quality
outcome measures. These independent variables were reported in the OAT and were all
dichotomous and categorical variables. The first independent variable included the
funding or payment system for the hospital. The funding payment system code was
“payment” and the data type was nominal defined as urban or Critical Access Hospital.
As cited earlier the urban organizations were considered Prospective Payment System
reimbursement with a fixed payment model (Centers for Medicare and Medicaid
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Services, 2015). The Critical Access Hospital payment type is a model that is for
organizations designated in limited service areas, with less than 24 acute care beds, and
has a 101% reimbursement of reasonable costs (Department of Health and Human
Services, 2014). The remaining four independent variables were questions from the OAT
regarding leadership actions that promote, guide, or use patient safety/quality lead actions
within their organization. The questions in Table 1 demonstrated the actual questions
from the OAT survey to hospital leadership. The questions from the OAT survey focused
on the use of data and communication of goals related to the clinical quality outcomes
and patient safety measures in the Partnership for Patients program (Centers for Medicare
and Medicaid Services, 2013). The independent and dependent variables and their
respective coding with data type are listed below in Table 2.
Table 2
Questions From the Organizational Assessment Tool (Independent Variables)
Leadership Questions
Region (Funding Payment System; Question #4)

Coding
Payment

Does hospital leadership use a checklist to assess the
priority of safety on strategic agenda of senior
leadership team, high-level operational meetings, and
board meetings? (Question #26)
Is there patient safety incident dashboard for
communicating risk management and lessons learned
information to senior management, the Board of
Directors, and hospital staff? (Question #85)
Are the Board and Governing Body activity involved in
risk management and patient safety decision making?
(Question #88)
Did your hospital have an event requiring a root case
analysis in the last two years where the root cause was
determined to be lack of proper and timely
communication between staff? (Question #102)

Checklist

Data Type
Nominal (Urban,
CAH)
Nominal (yes, no)

Dashboard Nominal (yes, no)

Decision

Nominal (yes, no)

Root
Cause

Nominal (yes, no)
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The dependent variables were measures from the Partnership for Patients program
and include Hospital Acquired Infections, Thromboembolism, and falls during an acute
stay. The dependent variables were the occurrences of the clinical outcomes in the patient
population receiving services at the participating organizations. The dependent variables
were ordinal and defined as the number of occurrences (continuous) in the reporting
period. The definitions for each of the dependent variables were from clinical best
practice and implementation of practices to reduce harm in healthcare organizations
(Centers for Medicare and Medicaid Services, 2011).
Table 3
Occurrence of Clinical Quality Outcomes (Dependent Variables)
Variable
Catheter-associated urinary tract infections
Central line associated blood stream infections
Falls with injury during hospital stay
Venous Thromboembolism rates

Coding
CAUTI
CLABSI
Fall
VTE

Data Type
Ordinal (number
of occurrences)

Variable scale & scores. The scales for each of the independent variables were
nominal or ordinal in type and were presented in a categorical and continuous manner for
analysis. The dependent variables were all ordinal in type and can range from zero (did
not occur) to unlimited occurrences. Each of the scores were either yes/no (categorical) or
a whole number (of occurrences in a continuous series).
Variable measurement. The calculation included both t-tests and multiple
regression tests for each of the variables. There was a t-test for each of the independent
variables related to each of the dependent variables to analyze if there is a difference
between the impacts of the independent variable on each of the dependent variables. A
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multiple (linear) regression was completed for the independent variables to each of the
dependent variables.
Data Analysis Plan
Analysis software. The data analysis plan was to receive the data from the source
organization and place all data in a secure external non-networked drive. The participants
(organization) confidentiality remained intact as the participating organizations were not
identified in the release of information (data). Then the data were entered into the SPSS
(version 21) software for analysis. The independent and dependent variables were coded
as stated earlier. The data, through the SPSS program, was then analyzed through a series
of multiple regression tests between the multiple independent and each dependent
variable to predict their predictive relationship. Each independent variable group
(leadership actions and payment system) was related to each of the dependent variables
through the multiple regression tests.
Analysis software & cleaning. Analysis was completed in statistical software,
SPSS, with the latest updates and version for data entry and comparisons. Descriptive
statistics, including means and standard deviations, were completed prior to the data
analysis for fit and normal distributions. When determined there was unacceptable or data
that had missing values it was cleaned for data integrity in the results. Data was cleaned if
there were missing fields (non-reported results) for some of the variable entries. If data
happened to be missing from the original data set, cleaning was attempted in order to be
resolved. Also if data results were determined to be representing other demographic
elements, it was determined to be removed from the analysis.
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Research question - Null Hypothesis (H0): There is no statistically significant
predictive relationship between hospital funding source, the occurrence of hospital
leadership activities (safety checklist, creating a dashboard, board involved in decision
making, root cause analysis), and clinical quality outcomes (fall rates, venous
thromboembolism, catheter-associated urinary tract infections, and central line associated
bloodstream infections) as measured by the associated Partnership for Patients (Centers
for Medicare and Medicaid Services) criteria.
Alternative Hypothesis (HA): There is a statistically significant predictive
relationship between hospital funding source, the occurrence of hospital leadership
activities (safety checklist, creating a dashboard, board involved in decision making, root
cause analysis), and clinical quality outcomes (fall rates, venous thromboembolism,
catheter-associated urinary tract infections, and central line associated bloodstream
infections) as measured by the associated Partnership for Patients (Centers for Medicare
and Medicaid Services) criteria.
Statistical testing. Multiple tests were conducted to study the relationship
between the leadership behaviors and the performance within the clinical quality
outcomes. The statistical testing plan for each of the variables presented in this study
included both multiple linear regression tests and t-tests. There were a series of multiple
regression tests for analysis of the leadership actions and federal payment type
(independent variables) to analyze their relationship to each of the dependent variables.
Therefore a series of multiple regression tests with the models of independent variables to
individually predict the relationship to each of the dependent variables. These tests were
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appropriate for the data because the dependent variables are ordinal (number of
occurrences), there are several independent variables used, and the test indicated which
are the best predictors (California State University, Northridge. (n.d.). There were a series
of t-tests to analyze the difference between the four leadership questions and the payment
type to each of the clinical quality outcomes based on the t-test. The t-tests, within the
linear regression analysis, determined the degree of slope for the regression analysis and
determine the strength of the relationship between the independent and dependent
variables (Frankfort-Nachmias & Nachmias, 2008).
Interpretation. There was an inclusion of co-variates for the independent
variables to be included in the study to determine influences on quality outcomes. The
results listed and displayed on regression charts for support for either the null or
alternative hypotheses. Finally, a presentation of the information in table form to compare
the different range of relationship between the predictor and criterion variables.
Threats to Validity
To determine the strength and limitations of the study, threats in instrumentation
were considered first. There are strengths to the measurement tool in the area of validity
and reliability as demonstrated by the OAT from Centers from Medicare and Medicaid
Services (Econometrica, Inc., 2013). Content validity was seen as the largest of validity
limitation because the participants could have a different set of leadership behaviors that
they feel or have used in their organization (Frankfort-Nachmias and Nachmias, 2008)
and the reporting tool may not have indicated these interventions due to the tool not
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addressing other interventions. It would be nearly impossible to determine if those
leadership actions were being considered when answering the questions to the survey.
The influence of other experiences or knowledge is certainly a concern for this
research (M. Nugent, personal conversation, January 4, 2016). The organizations for the
Partnership for Patients program signed a contract in the being of the program in 2010
and agreed to submit the clinical quality of care data, implement best practices, and
completed the organizational assessment surveys (M. Nugent, personal conversation,
January 4, 2016). Because of this relationship, the organizations may have been
influenced by the perceived value of the program to implement changes. In addition, a
concern is the reliability of the testing instrument (M. Sheppard, personal conversation,
February 19, 2016) because of the limited release of information for test development it
was unclear how the OAT was tested prior to use, other than a 13 organization pilot test
(Econometrica, 2013). The instrument was a survey based on an ordinal ranking scale
and would allow the participants to self-select and determine the level of behavioral
influences. A test-retest method would have strengthened the reliability of the testing
instrument and determined that the participant's results are truly the intended results
(Frankfort-Nachmias and Nachmias, 2008). In addition, this may be minimized by having
a standard operating definition for the survey ranking (Frankfort-Nachmias and
Nachmias, 2008). Overall, the fact that the instrument for this study may have been
previously tested for validity and reliability may prove to be strength for the study
(Econometrica, 2013). Other limitations could include the rate of survey return and
participation for the study. These could be challenges due to the technology of the survey
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or the determined value in the participation. However, the purpose of the study was to
begin to link the leadership actions to clinical results and it may prove to be a more
exploratory study.
Since the study was conducted with secondary data, there is limited direct bias of
the researcher. However, the data source that collected the leadership behaviors,
conducted the OAT, for the data set may have had some influence with the organizations
who reported. The Iowa Healthcare Collaborative collected the leadership survey data
and reviewed the action plans throughout the Partnership for Patients program. This
review by the data source may have some organizations to improperly report the
leadership actions taken in their organization. This bias was addressed in the limitations
of the study. According to the Iowa Healthcare Collaboration Vice President of
Operations, Meg Nugent, the organization has not published the results from the OAT
survey (M. Nugent, personal conversation, January 4, 2016). They have considered the
OAT data complements the clinical quality outcome data and no independent testing was
completed for validity and reliability.
Ethical Procedures
Agreements for data access and study analysis were completed prior to the actual
access of the data. All ethical procedures were addressed through the study, also having
an external review by the Institutional Review Board (IRB; Walden University, 2015).
IRB ensured that the study does not reflect any validity or ethical concerns with the
study’s methods or procedures. Documents from IRB review are included in Appendix D
including the agreements to gain access to data and the use of human participates.
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Criterion-referenced tests are intended to measure how well a person has learned a
concept (Frankfort -Nachmias and Nachmias, 2008). This study did not investigating the
knowledge level of the leaders, yet the attitude toward the behaviors and the comparisons
among the leadership. Therefore, the design of the test does not increase the ethical
concerns for the study. One of the other concerns was the informed consent of the
participants. This was controlled by the data source organization gaining a preprogram
Charter or agreement with the reporting hospitals and the ability for the participants to
remove themselves from the study during the survey. Other ethical implications were
neutralized by disclosing any process defects or errors, maintaining professional codes of
research (example no deception or invasion of privacy) through full discloser of process.
This research included a process to de-identify all organizations in the data and reduce
any bias for results from particular organizations or leadership. De-identification was
completed by the data source prior to sending the secured file. The confidentiality of all
results was maintained by blinding the identifier for the participants, only results were
available.
Other ethical concerns include the use of human subjects and the security of the
data. No human subjects were used in this study. This study proceeded through the
Institutional Review Board (IRB) process at Walden University (2015) in May 2016. The
IRB process reviewed the data collection method for primary research, sensitive topics
such as legal or illegal proceedings, and vulnerable populations. This study does not
contain any of the immediate high-risk areas; however, IRB still reviewed the plan for the
study prior to data exchange from the data source. Only the determinations of post
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treatment outcome were studied and the study was initiated after the clinical intervention
was completed in the hospital organizations. It is determined that there was statistical
analysis with software such as SPSS, which allowed for the participants’ information to
be entered and stored with confidentiality and identification only by a case number. The
exchange of data was done through an encrypted; secure (password protected) email
method with storage encrypted. The information was then be securely encrypted and
backed up with the platform of the software download. The information and details of the
survey results will also be destroyed following the (statistical analysis) and final approval
for the doctoral degree.
Summary
The quantitative cross-sectional study addressed the relationship between the
independent variable of leadership actions, federal funding designation, and the clinical
care outcomes for hospitals across the state of Iowa. The statistical analyses attempted to
determine if there was a relationship between the different independent variables and the
clinical outcomes (dependent variables). Results of research, such as those related to
clinical outcomes, could have an effect on the competencies and behavioral dimension of
leadership performance. However, researchers need to continue to link the importance or
value of each leadership competency by explaining the impact to organizational results. It
is supported that the concepts of leadership performance in the application of innovation,
strategic planning, creating and realization of vision, growth and management, and
project/change management (Planima and Skarzauskiene, 2010). However, this study
created the continual discovery for the support between leadership performance and
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clinical quality outcomes (results) by demonstrating how the quantitative cross-sectional
methods demonstrate statistically such as relationship. This study attempted to determine
such an impact of leadership actions related to the quality of the organization. Related to
leadership's use of systems thinking theory was from Haines (1998) "one of the ways to
improve the quality of results of an activity is to enhance the quality of thinking: how you
think, is how you act, is how you are". In addition, leaders begin to use consistently the
theory of their actions in their management; the organizational performance may have
significant improvement in the outcome or results.
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Chapter 4: Results
Introduction
The purpose of this study was to investigate the relationship between leadership
actions, U.S. federal funding sources and/or payment types, and the clinical quality
outcomes as defined by the Centers for Medicare and Medicaid Services (CMS)
Partnership for Patients/Hospital Engagement Network. The study determined how
healthcare leadership actions contributed to driving the performance of the organization’s
result for better quality outcomes. Healthcare organizations across the U.S. have worked
to improve their quality outcomes provided to the patients following several publicized
statements from government agencies (e.g., Agency for Healthcare Research and Quality,
2015). The results of this study are intended to guide leadership within healthcare
organizations to continue to provide value-added services.
Research Question
Research Question: What is the predictive relationship between hospital funding
source, the occurrence of hospital leadership activities (safety checklist, creating a
dashboard, board involved in decision making, root cause analysis), and clinical quality
outcomes (fall rates, venous thromboembolism, catheter-associated urinary tract
infections, and central line associated bloodstream infections), as measured by the
associated Partnership for Patients (Centers for Medicare and Medicaid Services)
criteria?


Null Hypothesis (H0): There is no statistically significant predictive relationship
between hospital funding source, the occurrence of hospital leadership activities
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(safety checklist, creating a dashboard, board involved in decision making, root
cause analysis), and clinical quality outcomes (fall rates, venous
thromboembolism, catheter-associated urinary tract infections, and central line
associated bloodstream infections), as measured by the associated Partnership for
Patients (Centers for Medicare and Medicaid Services) criteria.


Alternative Hypothesis (HA): There is a statistically significant predictive
relationship between hospital funding source, the occurrence of hospital
leadership activities (safety checklist, creating a dashboard, board involved in
decision making, root cause analysis), and clinical quality outcomes (fall rates,
venous thromboembolism, catheter-associated urinary tract infections, and central
line associated bloodstream infections), as measured by the associated Partnership
for Patients (Centers for Medicare and Medicaid Services) criteria.
This chapter describes the data collection, study analysis techniques, and variables

for the analyses, as well as the descriptive statistics, assumptions, statistical analysis, and
post-hoc analysis and additional statistics completing during the study.
Data Collection
The Hospital Engagement Network program Partnership for Patients began in
2012 with hospital quality outcome data collected by the Iowa Healthcare Collaborative,
quarterly from 2012 until 2014 (Iowa Healthcare Collaborative, 2015). Recruitment for
the Partnership for Patient program was completed by the Iowa Healthcare Collaborative
and followed the same timeframe as the data collection. The Iowa Healthcare
Collaborative was also the data source for all secondary data in this study. The data used
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in this study including the leadership actions (independent variables) and clinical quality
outcomes were collected in the final quarter of 2014 using the Organizational Assessment
Tool (OAT).
Discrepancies in Data Collection Plan
There was a discrepancy in the final sample size for the population in the study. I
initially that there would be data from 118 hospitals included in the provided secondary
data. However, some organizations discontinued data reporting during the program, so
the final number of participating hospitals reporting leadership actions was 105. In
addition, some hospitals did not submit all data for the dependent variables and missing
data points have been classified as missing data from the study. Final response rates for
variables were 105 organizations reporting the predictor variables and within the data set
the response size were: catheter-associated urinary tract infections (CAUTI) measures, n
= 67; central line associated bloodstream infections (CLABSI), n = 50; falls with injury
measures, n = 98; and venous thromboembolism (VTE) measures n = 96.
Sample Demographics Compared to Population
The sampling method used for the study was a convenience sampling of a
secondary data source tracking participating hospitals across state of Iowa. The sample is
representative of the hospitals in Iowa, with a mix of urban and rural facilities. According
to the United Health Foundation (2016), Iowa can be generalized for the type of
healthcare organizations and is very similar to other states across the country with a mix
of (urban) prospective payment system hospitals and rural cost based funding (or Critical
Access Hospital). The Iowa Hospital Association (2016) placed the population of Iowa at
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a rank of 30th in size and demographic of rural hospitals versus urban hospitals for size
and location. There are approximately 1,332 (23%) Critical Access Hospitals across the
U.S., out of 5,627 total hospitals, with only five states not participating in the federal
hospital status (Rural Health Information Hub, 2016). These states that do not have
designated Critical Access Hospitals still have facilities that are under the bed size of 25
(federal qualifications) and are similar in payment funding, with similar quality outcome
regulations (Rural Health Information Hub, 2016).
Sample characteristics and relationship to the population are seen in the
demographics of organization size, payment model, and criteria of clinical quality
outcomes. Demographic representation of the sample include 26 prospective payment
system hospitals including large, urban centers, Rural, and Rural Referral systems who
are all paid through the prospective payment or PPS system. There are also the remaining
(n = 79) Critical Access Hospitals are paid on a cost-plus basis however Federal
Regulations require them to be small in nature and payment is based on a cost-plus
nature. All organizations in the study previously met the same clinical procedural or
protocol criteria for each of the quality outcomes (dependent variables), as established by
CMS (2012). These clinical procedures or outcome measures do not vary based on size or
location of the organization. Since some of the organizations did not report the clinical
quality outcomes for each of the dependent variables of the CAUTI and CLABSI,
measures did fall below the preferred sample size. These results indicated that the power
(or probability of error) only meet expectations for falls with injuries and VTE with a
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power of .99 for each dependent variable. In Table 4 lists other power calculations, effect
size and R Squares for each of the dependent variables.
Table 4
Power Calculations for Each Clinical Quality Outcome (Dependent Variable) Using Five
Predictor Variables, Effect Size Calculated With R2, and Alpha of .05
Dependent Variables
Catheter-Associated Urinary Tract
Infection (CAUTI)
Central Line-Associated Blood Stream
Infections (CLABSI)
Falls with injuries from immobility
Venous Thromboembolism (VTE)

N

R

Effect
size

67

.056

.06

.27

50
98
96

.108
.244
.293

.12
.32
.41

.39
.99
.99

2

Power (error
probability

Results
This study was designed to investigate the relationship between leadership
actions, federal funding systems, and clinical quality outcomes across Iowa hospitals. The
purpose is to summarize key findings and to include a solid framework for the
recommendations, generalizability, and influence of social change. Social change implies
that there was a result of the study that would be a recommendation for leaders for
behaviors modification that could influence the larger society toward the good. The focus
of the social change section related the results of the study to the possible implications for
leaders and how to improve the outcomes of a healthcare organization.
Descriptive Statistics and Variables
An analysis was conducted to compare the relationship of hospital funding type
(payment) and leadership actions to the clinical quality outcomes of CAUTI, CLABSI,
rates for Falls with Injury, and VTE. The following is a list of the variables in the study.
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Each dependent variable was studied for relationship to the group of predictor
(independent) variables. As stated prior final response rates for variables were 105 Iowa
hospital organizations reporting the predictor variables for a frequency of 89% of
hospitals reporting the OAT assessment. Within the data set, the response size for the
criterion (dependent variable) outcomes were CLABSI with the lowest response rate (n =
50, frequency 47%), followed by CAUTI measures (n = 67, frequency 63%), then two
variables met a power calculation above the desired 80%, were VTE measures (n = 96,
frequency 91%) and the highest response variable of falls with injury measures (n = 98,
frequency of 93%). The range of the dependent variable is from n = 50 to n = 98 and a
mean of the n = 78. Table 5 and Table 6 contain the descriptive statistics for each of the
reporting and non-reporting organizations from the OAT (five predictor/independent
variables) and the clinical quality outcomes (criterion/dependent variables).
Table 5
Descriptive Statistics for Independent Variable with Reporting and Frequency
Independent Variables*
Funding Payment – Reporting Organizations
Funding Payment – Non-reporting
Total Organizations

n Frequency %
105
89%
13
11%
118

Leadership Checklist –Reporting Organizations
Leadership Checklist – Non-reporting Organizations
Total Organizations

105
13
118

89%
11%

Dashboard for Communication–Reporting Organizations
105
Dashboard for Communication – Non-reporting Organizations 13
Total Organizations
118

89%
11%

Board in Decision Making –Reporting Organizations
Board in Decision Making – Non-reporting Organizations
Total Organizations

89%
11%

105
13
118
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Root Cause for Events – Reporting Organizations
105
Root Cause for Events – Non-reporting Organizations
13
Total Organizations
118
* Population for data set was 127 with 118 organization reporting

89%
11%

Table 6
Descriptive Statistics for Dependent Variables (N = 105)
Dependent Variables**
CAUTI rates
CLABSI rates
Falls with Injury
VTE rates

M
.13
.04
.52
.38

SD
.489
.283
1.203
1.275

n
67
50
98
96

Statistical Analyses
Several statistical analyses were conducted to determine the relationship between
leadership actions, funding type, and clinical quality outcomes. The analyses for this
study included tests for assumptions, t test, multiple linear regression, and additional
multiple logistic regression. Each of the tests used applicable information for the
predictor and criterion variables which were all from secondary data collected on the
population of Iowa hospitals. Significant results are presented in the following sections
and complete results can be found in the respective appendixes.
Assumptions. The analyses for this investigation included correlation analyses, ttests for variable means, and multiple linear regression tests for the clinical outcomes of
CAUTI, CLABSI, VTE, and falls with injuries. Summary information for the correlation
analyses, t-tests and linear regression results are presented here with detailed information
located in Appendix E, F, and G respectively. There are four assumptions with these
analyses (correlation analyses, t-tests and multiple linear regression) including normality
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or normal distribution outliers, homoscedasticity, diminished sample size,
multicollinearity, and independent errors (Field, 2013). The first two assumptions are for
outliers and homoscedasticity in both the independent and dependent variables and, if
needed, can be data cleaned prior to completing the analyses (Field, 2013; Marrow, n.d.).
Data cleaning was completed and absent (non-reported) values coded in the database as
“missing” (“999”) prior to the analysis. The homoscedasticity is when the variables have
the same level of variance and this can be overcome by using the weighted squares
regression results as needed and can be detected by reviewing the scatter plots (Field,
2013). Both outliers and homoscedasticity were validated through regression (scatter)
plots of all four dependent variables; the histograms and normal p-p plot of regression
indicated normally distributed residuals or normal distribution of the bell curve for
analyses including t-test analysis. Since the values were indicated to be normally
distributed no further adjustments in the data are indicated (Field, 2013).
The third assumption was for cases when the sample sizes of the populations are
too small (Field, 2013). The appropriate number of cases in the sample (N) should be the
number of dependent variables (regression coefficients) to demonstrate a power of alpha
greater than .80 (Buchner, Faul, and Erdfelder, n.d.). This was not the case for CAUTI
and CLABSI G-Power calculations effect size of .27 and .39, respectively; however it
was the case for falls with injury and VTE (effect size of .99 for both). This indicates that
the results for all the regression analyses come with some concern for the results to
determine if the null hypothesis should be rejected or retained with confidence (Field,
2013).
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The fourth assumption was for multicollinearity, when at least two independent
variables are highly correlated to each other (Field, 2013). This resulted in larger standard
errors for the equation, and data cleaning was performed prior to testing as needed (Field,
2013). The results of correlation testing, through the Pearson’s Correlation Coefficients
can indicate where there is a very strong relationship (r < .8) between two variables and
one or more variables may be removed from the analyses to not confound the results
(Field, 2013). According to Field (2013), high Pearson’s Correlation Coefficient are
indicated when r > = .9. In this study, none of the variables had a high Pearson’s
Correlation Coefficient with the range of the values for all comparisons from -.406 < r >
.532, showing that there were no high correlations between variables in the data set.
Therefore, all of the variables can be used in the linear modeling, as recommended by
Field (2013). Further discussion of the variable correlation results can be found later in
the chapter.
The variance inflation factor (VIF) can also be reviewed for multicollinearity.
According to Bowerman and O’Connell (1990, in Field 2013), the average of the VIF of
considerably greater than one can indicate a biased of multicollinearity. The final
assumption is for independent errors, which is when two observations are truly
uncorrelated, and can be tested through the Durbin-Watson test (results from 0-4 with a 2
score are unrelated; Field, 2013). Appendix F includes the results of the Durbin-Watson
test for independent errors for the analyses. Each of the dependent variables had an
average VIF value near 1.0 so there was no concern about the relationship between
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independent variables. The results of the Durbin-Watson test indicate results near 2.0 so
there was no concern for independent errors in the dependent variables.
Correlations. The correlations between variables were examined by using the
Pearson’s Correlation Coefficient Tests in SPSS. This was completed to determine if any
of the variables (predictor or criterion) were highly correlated. According to Field (2013),
if any of the variables that have a high Pearson’s Correlation Coefficient (r < +/-) of .8 or
higher, one of the variables should be removed from the regression testing in order to not
confound the results. During this testing all of the variables for each of the criterion
variables with the predictor variables were compared. Results indicate that none of the
variables had a high correlation coefficient. The range for all variables was -.406 < r >
.523. Table 7 summarizes the results of the correlation testing for all variables and the
results of the complete correlation testing can be found in detail in Appendix E.
Table 7
Statistically Significant Results for the Pearson’s Correlation Testing Between Variables
Variables

Pearson’s’ Correlation

CAUTI - Funding to Root Cause
-.406
CLABSI – Funding type to Root Cause
-.354
CLABSI – Dashboard to Root Cause
-.309
Falls – Payment to Root Cause
-.377
Falls with Injury - Funding
.481
Falls – Decision making to checklists
.215
VTE – Funding to Root Cause
-.381
VTE rates - Funding
.523
** Correlation is statistically significant to the p < .01 level (2-tailed)
* Correlation is statistically significant to the p < .05 level (2-tailed)

Sig p value
(2-tailed)
.001**
.012*
.029*
.000**
.000**
.034*
.000**
.000**

Statistical t-Tests. Statistical t-tests were completed on the predictor criterion
variables that presented statistical significance in the linear regression testing. Statistical
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t-tests were completed to determine the differences in the means and to compute the
standard error for variability between sample means (Field, 2013). The evaluation of each
of the dependent variables was calculated with a determination of effects by the each of
the independent variables. Statistical t-tests were completed for each of the dependent
variable with statistically significance demonstrated on three of the five independent
variables. Table 8 demonstrates the results for each independent and dependent variables
with statistical significance.
Table 8
Results for Each Variable and Statistically Significant Outcome
Independent Variables
Hospital Funding / Payment
Hospital Funding / Payment
Hospital Funding / Payment
Leadership uses safety Checklist at meetings
Leadership creates a safety Dashboard for goals
Leadership involves the Board in safety Decision Making
Leadership determines Root Cause was communication
Leadership determines Root Cause was communication
* Correlation is statistically significant to the p < .05 level
**Correlation is statistically significant to the p < .01 level

Dependent
Variable*
CAUTI*
Falls**
VTE**
CLABSI*,
none
none
Falls*
VTE**

Sig. p
value
.044*
.000**
.000**
.037*
.040*
.008**

Testing for the relationship between the predictor variables Federal Funding –
Payment type based on Region (Funding-Payment) and Root Cause for Events with both
the criterion (dependent) variables of falls with injuries and VTE. Statistical tests for
means, including the independent t test, were completed because the outcomes of the
correlation analysis to determine the differences between means. Table 9 represents the
statistically significant results for the t test when comparing the means and the results of
the entire t test analysis can be found in Appendix G.
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Table 9
Statistically Significant Results for the t Test Comparisons of Means
Dependent
Variable
Falls

Difference in
Means
-1.35

Independent Variables
Funding between Critical Access and PPS
hospitals to
Root Cause completed and not completed
Falls
.396
Funding between Critical Access and PPS
VTE
-1.230
hospitals to
Root Cause completed and not completed
VTE
.613
** Correlation is statistically significant to the p < .01 level (2-tailed)

Sig
p value
.000**
.017**
.000**
.000**

Completion of t-test for funding type. The results for funding type in relationship
to the criterion variable of falls with injuries demonstrated organizations with funding
types of Critical Access Hospitals (CAH; M = .26, SE = .069), compared to those
organization with funding type of Prospective Payment (PPS; M = 1.61, SE = .361) with
a difference of means, -1.35, was statistically significant t(116) = -5.391, p = .000, and
represented a medium-sized effect, d = .66. The results for funding type to the criterion
variables of VTE rates demonstrated organizations with federal funding type of Critical
Access Hospitals (CAH; M = .01, SE = .012), compared to those organization with
funding type of Prospective Payment (PPS; M = 1.24, SE = .348) with a difference of
means, -1.230, was statistically significant t(113) = -5.584, p = .000, and represented a
medium-sized effect, d = .77.
These results indicated that for funding type there is a statistically significant
difference in the means between the funding types and falls with injury and VTE rates
and the results were not due to chance. For the results of the funding type to falls with
injury indicate that there is a statistically significant difference between the population
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from the Critical Access Hospital organizations and the Prospective Payment (PPS)
organizations. Indicating that the result could be contributed by the payment or funding
type with the larger mean contributed to the PPS hospitals. Results from the VTE rates
and funding type were also statistically significant between Critical Access Hospitals and
the PPS organizations, with Critical Access organization performing better than PPS.
This also indicates that the difference in means could be contributed to the manipulation
in the predictor variable. Organizational leadership often does not have a choice in
payment systems; however, that payment should not be the only predictor of quality
performance.
Completion of t-tests for Root Cause. The t-tests for the predictor variable of root
cause completed and the criterion variable of falls, organizations with completed root
cause analysis for events (M = .71, SE = .195), compare to those organizations who did
not complete a root cause with events (M = .32, SE = .107), with a difference of means,
.396, was statistically significant t(98) = 1.651, p = .017, and an effect size, d = .67. The
t-tests for predictor variable of root cause and VTE rates, organizations with completed
root cause analysis for events (M = .64, SE = .221), compare to those organizations who
did not complete a root cause with events (M = .02, SE = .023), with a difference of
means, .613, was statistically significant t(96) = 2.445, p = .000, and an effect size, d =
.77.
In this predictor variable, root cause, the leadership of the organizations stated
that they performed a root cause analysis and found that the reason the error occurred was
because of communication. For both falls with injury and VTE the results indicated that
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there was a statistically significant difference in the means between organizations that did
not perform a root cause analysis to those that did perform a root cause analysis, and
these results were not due to chance. This indicates that organizations who did complete
the actions and discovery within a root cause analysis could contribute some of the
improvement in outcomes to the activities to the root cause analysis. This supports the
actions of leaders creating a culture for improvement in communication and use of the
root cause analysis tool there should be a continual shift to better organizational
performance.
Multiple Linear Regression. The multiple linear regression analyses for each of
the dependent variables were run using a forced entry (“Enter”) model. The forced entry
model was chosen because there was low /no multicollinearity (all variables were kept in
model) and each of the predictor variables were of equal influence on the dependent
variable(s) (Field, 2013). Each multiple linear regression was conducted to evaluate how
well leadership actions and payment type predicted the criterion (clinical quality
outcomes – dependent variables). Table 10 demonstrates the variables used in the linear
regression analysis for models one through four. Each model was evaluated for the R2
value for best fit.
Table 10
Models for Linear Regression Variables
Models
1, 2, 3, 4
1, 2, 3, 4
2, 3, 4
3, 4
4

Independent Variables Included
Hospital Payment
Leadership uses safety Checklist at meetings
Leadership creates a safety Dashboard for goals
Leadership involves the Board in safety Decision Making
Leadership determines Root Cause was due to communication

83
Model 4 was determined to be the best fit for all of the criterion variables because
of the percent of variance (R squared). The percent of variance (r2), presented in Table 4,
were Catheter-Associated Urinary Tract Infection (CAUTI) r2 = .056, Central LineAssociated Blood Stream Infections (CLABSI) r2= .108, falls with injuries r2= .244,
Venous Thromboembolism (VTE) r2= .293.
Summary of statistically significant factors. Statistically significant factors for
the Model 4 multiple linear regression analyses include the following:


The linear combination of the predictors demonstrated a predictive
relationship to the outcome of falls with injuries occurrences at statistically
significant levels, F(5, 92) = 5.939, p = .000.



The individual predictors to the outcome of “Falls with Injury”, the results
indicate that there was a statistically significant predictive relationship by
predictors for 1-tailed significance with Funding Payment (p = .000) and Root
Cause for Events (p = .040).



The linear combination of the predictors there was a statistically significant
predictive relationship to the clinical quality outcome of VTE rates, F(5, 90) =
7.465, p = .000.



The individual predictors to the outcome of “VTE”, the results indicate that
there was a statistically significant predictive relationship by predictors for 1tailed significance with Funding Payment (p = .000) and Root Cause for
Events (p = .008).
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The results indicate there was not a statistically significant predictive
relationship to the co-variable predictors to the clinical quality outcomes of
CAUTI (p = .609) and CLABSI (p = .394).



There were individual detail significance in the clinical quality outcomes of
CAUTI with the predictor of Funding / Payment type (p = .044) and CLABSI
with the predictor of Leadership Checklists (p = .037), both meeting the p <
.05 level. However, the overall analyses for these criterions were not
statistically significant.

The multiple regression models were completed for each of the models to
determine the best fit for each of the criterion variables. In each situation the best fit was
model 4 and information throughout was represented in this model. Table 11 represents
the results for the multiple linear regression analyses for all criterions (dependent
variables). The information presented was discussed in further detail for each specific
criterion variable. It is presented in the chapter with complete results in Appendix H.
Table 11
Model 4 Multiple Linear Regression Analyses for the Criterion Variables
Dependent
R
R2* (% contributed)
df
F
Variables
CAUTI
.24
.056 (5.6%)
5, 61
.723
CLABSI
.33
.108 (10.8%)
5,44
1.062
Falls with Injury
.494
.244 (24.4%)
5, 92
5.939
VTE
.541
.293 (29.3%)
5,90
7.465
2
*R indicated the use of Model 4 for all criterion variables
** Correlation is statistically significant to the p < .01 level (2-tailed)

Sig (p
value)
.609
.394
.000**
.000**

The statistically significant results are indicated for falls with injury and VTE. Results
overall are not statistically significant for CAUTI and CLABSI outcomes for the models
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overall. These outcomes are statistically significant to the p < .01 level (p = .000). The
information presented is discussed in further detail for each specific criterion variables. It
is presented in the chapter with complete results in Appendix H.
Cather-Associated Urinary Tract Infection (dependent variable). The results
indicate after data cleaning that there was an N = 67 for Catheter-Associated Urinary
Tract Infection (CAUTI) outcomes, falling below the sample size indicators in the
population. It was noted that there was a small sample size (n = 67) that could impact the
effect size; however, the results are still presented in Table 12 with complete details in
the Appendix H for only the amount of sample size collected. It was not possible to
return to the organizations and collect further details after the reporting period of 2014.
The predictors were the four leadership actions and the federal payment type (Model 4),
while the criterion (dependent variable) was CAUTI. Model 4 was determined to be the
most appropriate model based on the largest of the R2 value (R2 = .056) and the strongest
of the correlations. The sample multiple correlation coefficient was .24, indicating that
only approximately 5.6% of the variable of outcome occurrences in the sample can be
accounted for by the linear combination of the predictors. The linear combination of the
predictors where not related to the outcome of CAUTI occurrences at a statistically
significant level, F(5, 61) = .723, p = .609. The ANOVA for the model demonstrate that
the overall data demonstrates that there is not a statistically significant relationship for the
five independent variables on the outcome of CAUTI when combined (p = .609). Table
12 also includes the details of the coefficients analysis for CAUTI using the results in
Model 4
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Table 12
Model 4 Multiple Linear Regression Coefficient Analyses for CAUTI
Coefficients
Constant*
Funding/ Payment by Region
Leadership Checklist for Meetings
Dashboard for Communication
Board involved in Decision Making
Root Cause for Event
*Model 4 with R2 = .056 with p = .609

B
-.185
.260
-.041
.039
-.085
.070

SE
.249
.144
.141
.128
.142
.138

Beta
.248
-.037
.040
-.076
.071

A statistically significant result for the single independent variable of funding/ payment
type (p= .044) was indicated for outcome of CAUTI. However, the overall criterion
statistical significance was not met (p = .609), the entire set of predictor variables
compared to the criterion dependent variable.
Central Line-Associated Blood Stream Infections (dependent variable). The
results indicate after data cleaning that there was an N = 50 for Central Line-Associated
Blood Stream Infections (CLABSI), falling below the sample size indicators in the
population. It was noted that there was a small sample size (n = 50) that could affect the
effect size; however, the results are still presented with complete details in the Appendix
H for only the amount of sample size collected. It was not possible to return to the
organizations and collect further details after the reporting period of 2014. The predictors
were the four leadership actions and the federal payment type (Model 4), while the
criterion (dependent variable) was CLABSI outcomes. This was determined because of
the largest R2 (R2 = .108) for the linear regression’s fourth model of additional regression
variables. The sample multiple correlation coefficient (R) was .33, indicating that only
approximately 10.8% of the variable of outcome occurrences in the sample can be
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accounted for by the linear combination of the predictors. The linear combination of the
predictors where not statistically significant related to the outcome of CLABSI
occurrences, F(5, 44) = 1.062, p = .394. The ANOVA for the model indicated that the
overall data demonstrated that there was not a statistically significant relationship for the
five independent variables on the outcome of CLABSI when combined (p = .394). Table
13 also included the details of the coefficients analysis for CLABSI using the results in
Model 4.
Table 13
Model 4 Multiple Linear Regression Coefficient Analyses for CLABSI
Coefficients
Constant*
Funding/ Payment by Region
Leadership Checklist for Meetings
Dashboard for Communication
Board involved in Decision Making
Root Cause for Event
*Model 4 with R2 = .108 with p = .394

B
.131
-.114
.168
.009
.057
-.081

SE
.154
.092
.095
.091
.092
.100

Beta
-.194
.256
.016
.095
-.129

When investigating the individual 1-tailed correlations for statistical significance
there is a statistically significance relationship between CLABSI outcomes and a single
predictor of Leadership Checklist for Meetings (p = .037). However, the overall
statistical significance was not met for the dependent variable when entering all of the
predictors.
Falls with Injury (dependent variable). The results indicate that after data
cleaning there was an incidence of n = 98 for falls with injuries, reaching the sample size
indicators in the population (power of .99). The predictors were the four leadership
actions and the federal payment type (Model 4), while the criterion (dependent variable)
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was injuries and falls from immobility (falls with injury) outcomes. This was determined
because of the largest R2 (R2 = .244) for the linear regression’s fourth model of additional
regression variables. The sample multiple correlation coefficient (R) was .494, indicating
that only approximately 24.4% of the variable of outcome occurrences in the sample can
be accounted for by the linear combination of the predictors. The linear combination of
the predictors were statistically significant related to the outcome of falls with injuries
occurrences, F(5, 92) = 5.939, p = .000. The ANOVA for the model demonstrate that the
overall data demonstrates that there is a statistically significant relationship for the five
independent variables on the outcome of “Falls with Injury” when combined (p = .000).
Table 14 also includes the details of the coefficients analysis for falls with injury using
the results in Model 4
Table 14
Model 4 Multiple Linear Regression Coefficient Analyses for Falls With Injury
Coefficients
B
Constant*
-1.303
Funding/ Payment by Region
1.358
Leadership Checklist for Meetings
-.005
Dashboard for Communication
-.105
Board involved in Decision Making
.300
Root Cause for Event
.021
*Model 4 with R2 = .244 with p = .000

SE
.451
.283
.259
.227
.251
.238

Beta
.473
-.002
-.043
.113
.009

When reviewing the individual predictors to the outcome of “Falls with Injury”,
the results indicate that there was a statistically significant relationship by predictors for
1-tailed significance with Funding Payment (p = .000) and Root Cause for Events (p =
.040). Further tests were conducted to further study the relationship of the predictors to
the dependent variable and were discussed in the t-test section.
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Venous Thromboembolism (dependent variable). The results indicate after data
cleaning that there was n = 96 for Venous Thromboembolism (VTE), reaching the sample
size indicators in the population (power of .99). The predictors were the four leadership
actions and the federal payment type (Model 4), while the criterion (dependent variable)
was VTE outcomes. This was determined because of the largest R2 (R2 = .293) for the
linear regression’s fourth model of additional regression variables. The sample multiple
correlation coefficient (R) was .541, indicating that only approximately 29.3% of the
variable of outcome occurrences in the sample can be accounted for by the linear
combination of the predictors. The linear combination of the predictors were statistically
significant related to the outcome of VTE rates, F(5, 90) = 7.465, p = .000. The ANOVA
for the model indicates that the overall data demonstrated that there was a statistically
significant relationship for the five independent variables, Model 4, on the outcome of
“VTE” when combined (p = .000). Table 15 also included the details of the coefficients
analysis for VTE rates using the results in Model 4
Table 15
Model 4 Multiple Linear Regression Coefficient Analyses for VTE
Coefficients
B
Constant*
-1.506
Funding/ Payment by Region
1.530
Leadership Checklist for Meetings
-.014
Dashboard for Communication
.328
Board involved in Decision Making
-.190
Root Cause for Event
-.112
*Model 4 with R2 = .293 with p = .000

SE
.465
.292
.273
.234
.258
.247

Beta
.507
-.005
.128
-.068
-.044

When reviewing the individual predictors to the outcome of “VTE”, the results
indicate that there was a statistically significant relationship by predictors for 1-tailed
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significance with Funding Payment (p = .000) and Root Cause for Events (p = .008).
Further tests were conducted to further study the relationship of the predictors to the
dependent variable and were discussed in the t-test section.
Post-hoc Analysis and Additional Statistics
Multiple binary logistic regression analyses were completed for the predictive and
criterion variables for additional statistical tests. Logistical regression tests determined
the prediction between categorical variables and within the analyses of the odd ratio
determined how much each independent variable predicts the dependent variable (Field,
2013). In this study, the dependent variable was not classified as categorical, so in order
to run the logistic regression analyses the dependent variables were classified as 0 =
“none” and 1 = “occurrences”. Healthcare organizations that reported any dependent
variable (clinical quality outcomes) as 1, 2, 3 … were coded as having “occurrences”.
Therefore, dependent variables included were 0 = no occurrences of outcome and 1 =
occurrences of clinical quality outcome. Independent variables included in the logistic
regression were funding type, checklists, dashboard, decision making, and root cause
analysis.
The results of the analyses included the best Block or model fit (-2 log
likelihood), test for model coefficients Chi-square and significance (Omnibus test
significance / non-significance since prior model), the assessment of how well the model
fits the data (significance/non-significance in the Hosmer-Lemeshow goodness-of-fit
statistic) and the odds ratio for the appropriately fit Block. The blocks were chosen for fit
because the differences in the blocks -2Log Likelihood, the statistically significant
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Omnibus test, and Hosmer-Lemeshow test were not statistically significant. Table 16
demonstrates each of the dependent variable’s model and results for independent
variables that were statistically significant for best fit model.
Table 16
Multiple Logistic Regression Analyses for Each of the Criterion Variables
Dependent
Variables
CAUTI

-2 Log
Block* Likelihood
2
39.894

Omnibus
Model
Chi-square
52.987

Chisquare
Sig (p)
.017

Hosmer –
Lemeshow
Sig (p)
.154

CLABSI

2

12.673

56.642

.000

.082

Falls with
Injury
VTE

1

96.795

39.062

.000

-

1

41.093

91.991

.000

-

Exp. (B) –
(odds ratio)
Payment =
.108
Checklist =
.270
Payment =
.167
Checklist =
.000
Payment =
.188
Payment =
.014

*Best fit blocks results presented
For all of the dependent variables when the odds ratio is less than one it means as
the odds (or probability) of the independent variable increased the odds of the dependent
variable decreased. The statistically significant results for the Logistic Regression
indicate that the odds ratio of less than 1, the predictor increases the odd of the criterion
decreases (Field, 2013). Results of the logistic regression indicate


Organizations with PPS payment are .108 times more likely to have occurrences
of CAUTI and .167 times more likely to have occurrences of CLABSI than
Critical Access Hospitals.
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Organizations that demonstrate leadership checklists are .270 times more likely to
have occurrences of CAUTI and not effect for CLABSI than organizations that do
not.



Organizations with PPS payment have .188 times and .014 times more likely to
have occurrences of falls with injury and VTE than Critical Access Hospitals.

Because all odds ratios are less than 1 indicating that as the number of predictors
increase, the odds of the clinical quality outcome decrease.
Summary
These results details were investigated, scrutinized, and possible future
recommendations are explored in Chapter 5. In this conclusion chapter, results were
explored in the area of interpretation of the findings in relationship to the theoretical
framework and scope of the findings. Also presented in the chapter was to explore the
limitations of the study and ability to generalize from the analyses. Finally, the final
chapter explores recommendations for future research with strengths and limitation of the
study, with implications of this study for the social change for healthcare organizations
struggling with performing at the highest level or standards.
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Chapter 5: Discussion, Conclusions, and Recommendations
Introduction
The purpose of this study was to determine the relationship between leadership
actions, federal funding type, and the clinical quality outcomes in hospitals across the
State of Iowa. The leadership actions and other variables that were investigated were
implementing leadership checklist, safety results in a dashboard, discussion with the
board regarding quality outcomes, root cause analysis with events, and the federal
funding type for hospital payments. Statistical test of multiple linear regression tests were
completed to compare these predictor variables to the clinical quality outcomes of
CLABSI, CABSI, Falls with Injury occurrences, and VTE rates. Healthcare organizations
have been working to improve the quality of care for years with some program
implementation support at the policy level (CMS, 2013). Analyses were completed to
investigate the relationship between the variables to determine if there were potential
benefits of the national effort to improve quality of healthcare such as the Partnership for
Patients (CMS, 2011).
The null hypotheses were accepted for the overall relationship between the
predictors and the outcome variables. Key results indicated that overall for the
investigation into the relationship between the leadership actions, funding type, and
clinical quality outcomes, there are mixed and overall results were not statistically
significant in any of the analyses (t test, multiple linear or logistical regression tests).
However, with further investigation, and split of the data into the multiple regression
testing, it appears that there was statistically significant relationship for two of the four
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criterion variables of funding-payment type and the clinical quality outcomes of falls with
injuries (p = .000) and VTE outcomes (p = .000). More specifically, Funding/Payment
type and Root Cause for Events had the common occurrences of statistically significant
results for falls with injuries and VTE outcomes when using t-tests between the different
groups of Funding/Payment and Root Cause for events designations.
Interpretation of the Findings
The findings for my study illustrate the relationship between leadership actions,
funding or payment type and clinical quality outcomes. In this chapter, the results are
discussed in regards to the analyses and findings, limitations of the study,
recommendations for future studies, and implications for organizations. A summary of
findings with the acceptance or rejection of hypotheses for the research question is
provided in Table 17.
Table 17
Summary of Findings for the Overall Hypotheses and Individual Variables
Accept Null
Accept Alternative
Hypotheses
(Reject Alternative)
(Reject Null)
Criterion Significance (p)*
Overall
X
CAUTI
X
.609
CLABSI
X
.394
Falls with Injury
X
.000**
VTE
X
.000**
*Model 4 used for all criterion
**Statistically Significant with p < .01
Further discussions of these findings are described in the upcoming sections including the
next step for future research.
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Comparison of the Results With Prior Literature
Pronovost and Jha (2014) questioned the effectiveness of the Partnerships for
Patients program, critiquing it for poor program design, weak validity of clinical outcome
measurements, and a lack of peer-reviewed results submitted for program evaluation. My
study did not investigate these factors as Pronovost and Jha (2014) did; however, my
study’s findings did continue to support or confirm the validity of questions related to the
measurements of the clinical quality outcomes. The support for my study’s null
hypotheses is in alignment with Pronovost and Jha (2014) statements that the methods
within the Partnership for Patients program did have some questionable methods of
implementing sustainable or impressionable processes to assist with increasing the
benefits of patient care. I specifically found support for some concern with the results of
the Partnership for Patients program related to the validity and reliability of the
leadership actions that were reported.
In contrast, my study’s results supported the work by DuPree (2016) and the Joint
Commission. DuPree (2016) stated that high reliable organizations are less likely to have
errors (i.e., increased rates of harmful outcomes) within the medical care. DuPree (2016)
found that high reliable organizations have characteristics of leadership representing a
preoccupation with failure, ability to notice differences in process, sensitivity of changes
within operations, commitment to resilience, and engaging experts within the
organization. The actions that DuPree (2016) reported as common to highly reliable
leadership were not defined as leadership behaviors in my study. The highly reliable
leadership actions were also not representing in the leadership characteristics that were
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studied in organizations by the OAT survey as promoted and used as a leadership guide
by CMS.
DuPree (2016) stressed the importance of having experts who do the work and are
involved “at the front line” being involved in changes for better patient care. The
Partnership for Patients program focused increasingly on the development and
communication of leadership to the Board of Directors, however, not stressing that those
that do the work are involved with the changes to the work (Partnership for Patients,
2011). This could be an indicator of why falls with injury and VTE both had statistically
significant relationship to root cause analysis in my study. Generally root cause analyses
are done with the individuals at the employee level and thus may have a large impact on
changes to future processes and preventing future errors. Some of the other independent
variables, dashboard, checklist, and board involvement in decision making may be
beneficial for the Board of Directors support of the goals (transactional leadership).
One common characteristic between my study and the leadership characteristics
stated by DuPree (2016) was the focus on the transparency to the board in addition to the
managers, patients and staff, sharing through a dashboard. DuPree (2016) stated that
leadership and Board should focus on improving the quality of care, with the process
changes to achieve this improvement of care, at the healthcare worker level. Actions that
involve the Board of Directors rarely reach the general employee level, so if the efforts
do not reach the patient, it may not be effective in preventing harm. This difference in
vision and goals within leadership behaviors could indicate why the organizations focus
did not impact the clinical quality outcomes leading to improved patient care as

97
significantly in my study. Also, in highly reliable organizations, alignment of leadership
comes with trust and communication of the patient safety culture from leadership and
supported at the Board of Directors to all levels of the organization (DuPree, 2016). This
information about highly reliable organizations was missing within my study. My study
did not discuss or investigate the communication of leadership to the employee level,
only at the Board of Directors level through Board engagement activities.
Findings Related to Theoretical Framework
Previous researchers have supported the findings that transactional leadership is
focused on setting goals for the organization, as in the Partnership for Patients program,
and on aligning work for improvement (Lowe, Kroeck, & Sivasubramaniam, 1996).
However, this study indicated some of the effects of transactional leadership may be
limited for sustaining results. Lowe, Kroeck, and Sivasubramaniam (1996) studied
leadership effectives and the relationship between transformational and transactional
scales. They discovered that transactional leadership was effective; however
transformational leadership was found to have statistically significant results for
effectiveness. They found that transactional scales for management had low correlations
with effectiveness and some negative relationships to be statistically significant.
Judge and Piccolo (2004) also stated that support was significant for effectiveness
of results with transformational leadership, behaviors support reward for work, and
improved with rigor of work. However, Judge and Piccolo (2004) supported the use of
transformational leadership over transactional or laizzez-faire leadership. It is additional
identified that Bass (1985) when formulating the theory of leadership; he did not
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differentiate the difference between transformational and transactional. So this may
indicate that leadership relationship to outcomes, as investigated in this study, were not as
easy to control for, measure the relationship in organizational work, and determining
leadership actions as hoped in the Partnership for Patients program.
My findings supported that the Partnership for Patients program, which requested
organizations to implement transactional leadership characteristics, did not have a strong
a predictive relationship to the clinical quality outcomes and harm reduction. The concern
for my study would be if leadership style was not the main focus and the implementation
of the program based on just one style of leadership would be almost impossible to
determine from my study. More detailed review and study of leadership style to isolate
the difference between transactional and transformational programming in the healthcare
organizations is certainly called for. The Partnership for Patients program did create an
effort to focus on transparency, open communication, patient centered medical care (Iowa
Healthcare Collaborative, 2015). The results have been impressive for the state of Iowa
and one consideration is the low number of occurrences for any of the dependent
variables. The possibility for the outcomes to be biased by one or two occurrences may
also call for more pre-/post- or longitudinal study of the leadership behaviors, as did
Judge and Piccolo (2004).
Limitations of the Study
Limitations for my study include the sample size for each of the dependent
variables. Reporting organizations were smaller in size than originally desired for both
CAUTI (n = 67) and CLABSI (n = 50) dependent variables. These small sample sizes did
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reduce the power calculations and validity of the outcomes for these two criterion results.
An implication for future practice indicates that the program administrators could
consider a practice to return to non-reporting organizations and gain outcome measures.
Also this limitation does reduce the ability for confidence if results would be generalized
to other regions or type of organizations across the United States.
Earlier limitations of this study were described as the OAT reliability, validity,
and the possibility of survey bias from the individual completing the OAT assessment
survey. Following the statistical analysis of the study these limitations still exist including
the concern of reliability and validity of the Organizational Assessment Tool (OAT) to
accurately reflect the leadership actions within the organization.
Other limitations of my study included the ability to see a clear relationship
between the actions of leadership and the clinical quality outcomes with a bias toward the
perception of correct answers. The other possible limitation was the leader’s bias of the
results for the OAT survey. Leaders could have answered the questions on the assessment
tool as they perceived as correct, creating a bias and inaccurate results for the
assessments. One of the higher reliability outcomes indicated that Federal Funding or
Payment system methodologies do have a productive relationship on the clinical quality
outcomes. This could indicate that when organizations are paid for or rewarded for their
outcomes it is seen as a priority and opportunities to continually improve in these clinical
areas. This is in support of the mixed results for the relationship between payment and
clinical quality outcomes as presented by Lee et al. (2012). Lee et al. (2012) stated that
they found a minimal relationship for improvement as I did in the CAUTI and CLABSI
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results. I did find a statistically significant predictive relationship between the funding
type and fall and VTE rates. A recommendation would be to investigate the reliability
and validity of the OAT questions, provide changes to the questions as needed, and use
the revised questionnaire for further assessment of the healthcare organizations. Also, it is
recommended that specific analyses be completed in the areas of funding type and the
relationship to improvement of outcomes.
Recommendation
Further research is needed in the areas of leadership methodologies in theoretical
framework, differences in the clinical outcomes of an organization, and influence of
specific leadership actions within an organization. In my study only 89% of leaders
deployed checklist, decision-making to the board, root cause analysis, and
communication. Further studies are needed in the area of why certain leaders chose to see
the value in implementing these measures within their organization. As agencies in
decision making such as CMS (2012) and AHRQ (2015) put forth packages two leaders
that have validity and reliability to change and predict outcomes within the organization,
leaders need to be fully engaged and brought into these measures. Without proper or
complete implementation organizations may run the risk of not seeing the success of
these measures. Their studies are needed to investigate the differences in these change
packages and the potential predictability of best success.
Regarding the leadership methodologies my study, this could imply that the
transactional leadership was goal attainment and was only slightly correlated to the
clinical quality outcomes. Further studies are needed in which the influence of
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transactional leadership is as effective as other methodologies within an organization.
Lowe, Kroeck, and Sivasubramaniam (1996) and Judge and Piccolo (2004) described
transformational leadership as a higher association between effectiveness scales than
transactional leadership for organizational success in outcomes. These researchers have
shown that transformational leadership is more effective for outcomes within an
organization (Lowe, Kroeck, & Sivasubramaniam, 1996). Judge and Piccolo (2004) did
discuss that for some practical applications, the difference between transactional and
transformational leadership styles can become difficult to separate. It is recommended
that further research is needed for the practical application of change packages within an
organization that an agency such as CMS has asked organizations to deploy within their
organization. Further research could address leadership styles of programs such as the
Partnership for Patients, where leadership protocols could benefit from implementation of
styles that reflect transformative leadership versus transactional leadership styles.
Because there was a difference in the clinical quality outcomes of indicators
within my study, further research is needed on why there are differences between positive
outcomes such as health hospital acquired infection areas and outcomes such as falls with
injury and VTE rates. Other researchers could investigate why some clinical measure
actions are more successful in improving patient care than others.
Implications
As healthcare strives to improve the level of care that is provided to each and
every patient, research should support the improvement through understanding what adds
value and actions that may not be as beneficial to the goals of the organization. The
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implications for this research can be related to the positive social change as benefits of
healthcare organizations and the care that is received. The positive implication of this
study can be for leadership to understand which actions can lead to improvement of
organizational outcomes. The impact to positive social change and implications are
further reflected in the recommendations for future practice and study for the health
organizations and policy advocates.
Positive Social Change
Social change is described as the ability for research and other actions to change
the behaviors or perceptions of a group of individuals (citation). I was looking for the
impact of leadership behaviors and actions on patient safety and clinical quality outcomes
and these findings will certainly have a positive potential for social change. The areas of
potential social change are in two main categories: continuing to increase and provide
patient safety measures or better care in our Healthcare systems and the impact of
leadership's understanding of how their behaviors and actions can influence or predict the
sustainability and overall performance of their organization. Healthcare organizations
continually strive to provide better quality of care and services to the patients. The goal of
healthcare organizations is to have zero defects or potential harmful events within an
organization (DuPree, 2016). Healthcare organizations have been working to provide
better or safer care to patients for several years and looking at measures such as the
Hospital Engagement Network, which focuses on providing better care, as just one
initiative (Centers for Medicare and Medicaid Services, 2012). As we continue to strive
and provide better care organizations, need to understand what the environmental and
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systems impacts are and what could have a relationship to these outcomes. Recent
support from DuPree (2016) described part of healthcare organizations continuing to
reach the goal of zero defects or adverse outcomes is reached by leadership commitment,
a culture of safety and process for improvement.
Implications of this Study
Further study is needed on the differences in the leadership behaviors related to
the differences found between the clinical quality outcomes. I implied in this analyses
that future studies may need to look at the difference between departments and
relatability of the indicators or even the parts of the organizations that are perceived as
unit specific owners of the indicators. There were differences in clinical outcomes such as
CAUTI and CLABSI, versus a clinical outcome that may be seen as more organizational
improvement area overall, such as falls, where everyone in the organization seems to
relate to the improvement. Leaders also need to further investigate their dedication and
commitment to positive change within their organization and the determination of impact
for better outcomes. The differences in more hands on indicators such as the positive
impact of completing a Root Cause Analysis activity was seen as a trend between those
indicators that were just passively tracked and reported to outside agencies. Overall the
results indicate that Iowa organizations are performing quite well in all of the areas. This
implies that there could be differences in what is happening in Iowa versus other states.
Implications for the study to be conducted in other states or areas of the United States in
order to see the relationship and outcome in such areas would be warranted.
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Recommendations for Practice
This study explored those potential environmental factors and could influence the
leadership decision within their organization. Leaders could learn from this study and
determine how and what they are doing to impact their outcomes of their organization.
From a policy level CMS has ask and initiated several high-level initiatives to continue to
influence the quality of care that is driven across the United States (Center for Medicare
and Medicaid Services, 2014). My findings could begin to influence the programmatic
initiatives that are prescribed by an agency such as CMS. Finding a strong relationship
between certain leadership behaviors and clinical quality outcomes is potentially an
educational and policy-driven decision for certain behaviors over others. If we can
continue to predict which behaviors would have a positive influence on increasing the
safety of U.S. healthcare institutions, both individual organizational decision-makers and
high-level policymakers, could potentially request these behaviors are institutionalized
within their organization. For example, both falls with injury and VTE had a strong
statistically significant level for the funding type related to the clinical quality outcome.
One could begin to determine why the impact of the funding or reimbursement for
outcomes has the most statistical significance.
Several authors have implemented the idea of transactional leadership versus
transformational leadership with some results indicating that Transformative Leadership
leads to improved organizational outcomes (Lowe, Kroeck, & Sivasubramaniam, 1996,
Judge & Piccolo, 2004). I found in my findings that testing results that indicated
transformational leadership may indeed support better outcomes within an organization.
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To further clarify CMS’s intentions of both transactional and transformational leadership
within the organization, I recommend continuing to study theoretical or methodology
leadership and leadership’s actions within the organization to discover more relationships
between actions and outcomes. My study is just beginning of the conversation of these
leadership behaviors within the organizations related to the leadership methodologies.
Conclusion
Over the last two decades healthcare organizations have continually attempted to
drive out errors within medical care and improve the quality of services that are provided
to the patients. My study examined the relationship of leadership actions, organizational
funding (payment) type and these clinical quality outcomes that hospitals attempt to
improve for patients. My study was one small step to determine if programs, such as the
CMS lead Partnership for Patients, had a positive effect in the areas of leadership actions
and clinical quality outcomes.
One of the major trends in healthcare programming is the push for value based
payment models which include the improvement of clinical quality outcomes for the
patients. The leaders that continually link the relationship between value for the patient
and the financial performance of the organization may run the risk of creating a dual
paradigm that some healthcare leaders cannot manage. While healthcare organization
generally implemented the transactional leadership, and actions within their
organizations, my study had mixed results when implementing transactional leadership
behaviors and the influential relationship to the outcomes of clinical care. The predictor
variables of federal payment or funding type, which is a risk and reward system for
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improvement in clinical outcomes, and conducting root cause analysis for events were
statistically significant for two clinical measures of falls and VTE. Leadership actions the
influences on two outcomes (CAUTI and CLABSI) do need further research studies
because of lack of statistically significant results. These results begin to highlight the
difficulty with improving healthcare and the programing efforts of agencies such as
Centers for Medicare and Medicaid services which are beginning to focus on the value of
healthcare services (Centers for Medicare and Medicaid Services, 2016). Programs where
the perceived value is for the patient, that focus on improving clinical quality outcomes,
and effect payment for such services; and continue to drive the need for more studies to
investigative what drives organizational success.
In this study, I highlighted three major themes for the relationship of leadership
actions and clinical quality outcomes. First, organizations need to continually strive for
outcome improvement including data submission that allows for analysis of such data.
Without this submission, it is difficult for organizations to determine success. Second,
although leadership has influence of process through actions, it appears that risk and
reward such as payment models may have the largest influence for positive outcomes.
Finally, more investigation is needed into the complex and compelling nature of
healthcare to determine those predictor variables that create a stronger relationship to the
safety and value within the system. More research is needed on what statistically
significant factors that can drive value and patient safety.
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Appendix A: Organizational Assessment Tool (OAT)
Double click the first page of the document to open the entire OAT survey and
view the entire document in Adobe Acrobat Reader.

OAT.pdf
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Appendix B: Data Use – Letter of Agreement
Double click the image of the Data Use Agreement (page 1) to open the Adobe
Acrobat reader file and view the remaining pages.

DUA_Pavelka.pdf
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Appendix C: Material Use – Letter of Agreement
Double click the image of the Material Use Agreement to view the entire
document in Adobe Acrobat reader.

MUA_Pavelka.pdf
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Appendix D: Approval From Walden University’s Institutional Review Board (IRB)
The following is an email confirmation from the IRB committee from Walden
University dated May 17, 2016. Data was collected from the data source following the
confirmation of the approval. The confirmation email with approval number is 05-17-160445038, is attached and can be viewed below. Double click on image to open document.

Walden University
Mail - IRB Materials Approved - Sarah Pavelka.pdf
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Appendix E: Results for Pearson’s Correlation Coefficient Test
The following Tables 18 to 21 demonstrate the multiple results from the test for
Correlation for CAUTI, CLABSI, fall rates, and VTE occurrences. Each table has the
SPSS output for the respective criterion variable in the entirety. For summary information
see the section in the results where information is summarized after analysis.
Table 18
Correlations for CAUTI
Correlations

Funding

Checklist Dashbo

Payment

ard

Decision Root Cause CAUTI
Making

for events

(CAH or
PPS)
.124

.076

.098

-.406**

.211

.319

.542

.429

.001

.087

14.418

1.672

1.149

1.328

-6.149

3.179

.218

.025

.017

.020

-.093

.048

67

67

67

67

67

67

Bias

0

-.003

.000

.006

.000

.001e

SE

0

.128

.122

.114

.092

.129e

95% Conf. Lower

1

-.143

-.180

-.140

-.572

-.072e

Interval

1

.369

.301

.307

-.224

.447e

Pearson Correlation

.124

1

.042

.104

-.112

-.020

Sig. (2-tailed)

.319

.736

.404

.365

.872

Pearson Correlation

1

Sig. (2-tailed)
Sum of Squares and CrossFunding

products

Payment - Covariance
(CAH or

N

PPS)
Bootstrapd

Upper

Sum of Squares and Cross-

1.672

12.687

.597

1.313

-1.597

-.284

.025

.192

.009

.020

-.024

-.004

67

67

67

67

67

67

-.003

0

-.001

.004

.000

.019e

.128

0

.123

.113

.116

.112e

-.143

1

-.210

-.123

-.334

-.162e

.369

1

.279

.307

.118

.300e

.076

.042

1

-.183

.031

products
Covariance
Checklist

N
Bias
SE
Bootstrapd

95%
Confidenc
e Interval

Dashboar

Pearson Correlation

Lower
Upper

.169

125
d

Sig. (2-tailed)

.171

.138

.803

15.910

2.403

-2.910

.493

.009

.241

.036

-.044

.007

67

67

67

67

67

67

Bias

.000

-.001

0

-.004

.000

-.023e

SE

.122

.123

0

.124

.124

.119e

-.180

-.210

1

-.091

-.415

-.288e

.301

.279

1

.403

.058

.198e

Pearson Correlation

.098

.104

.169

1

-.028

-.051

Sig. (2-tailed)

.429

.404

.171

.820

.684

1.328

1.313

2.403

12.687

-.403

-.716

.020

.020

.036

.192

-.006

-.011

67

67

67

67

67

67

Bias

.006

.004

-.004

0

-.006

.032e

SE

.114

.113

.124

0

.122

.151e

-.140

-.123

-.091

1

-.273

-.306e

.307

.307

.403

1

.199

.212e

-.406**

-.112

-.183

-.028

1

-.031

.001

.365

.138

.820

-6.149

-1.597

-2.910

-.403

15.910

-.493

-.093

-.024

-.044

-.006

.241

-.007

67

67

67

67

67

67

Bias

.000

.000

.000

-.006

0

.003e

SE

.092

.116

.124

.122

0

.117e

-.572

-.334

-.415

-.273

1

-.220e

-.224

.118

.058

.199

1

.236e

Pearson Correlation

.211

-.020

.031

-.051

-.031

1

Sig. (2-tailed)

.087

.872

.803

.684

.803

3.179

-.284

.493

-.716

-.493

15.791

.048

-.004

.007

-.011

-.007

.239

67

67

67

67

67

67

e

e

e

e

e

0e

Sum of Squares and Cross-

.542

.736

1.149

.597

.017

products
Covariance
N

Bootstrapd

95%
Confidenc
e Interval

Lower
Upper

Sum of Squares and Crossproducts
Decision

Covariance

making

N

Bootstrapd

95% Conf. Lower
Interval

Upper

Pearson Correlation
Sig. (2-tailed)
Sum of Squares and Cross-

.803

products
Root

Covariance

Cause for

N

events
Bootstrapd

95%
Conf.Inter
val

Lower
Upper

Sum of Squares and CrossCAUTI

products
Covariance
N
Bootstrap

d

Bias

.001

.019

-.023

.032

.003
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SE
95%

.129e

.112e

.119e

-.072e

-.162e

-.288e

Lower

.117e

-

0e

-.220e

1e

.236e

1e

.306
e

Conf.Inter
val

.151e

Upper

.447e

.300e

.198e .212
e

**. Correlation is significant at the p < 0.01 level (2-tailed).
d. Unless otherwise noted, bootstrap results are based on 1000 bootstrap samples
e. Based on 998 samples

The following, Table 19, is the output from SPSS for the dependent (criterion
variable) of CLABSI. The information included the details analysis and summary
information can be found in the results section of the chapter.
Table 19
Correlations results for CLABSI
Correlations

Funding

Checklist Dashboard

Payment

Covariance

(CAH or

n

PPS)
Bootstrapd

Checklist

Cause
for

PPS)

events

CLABSI

.069

.221

-.354*

-.103

.530

.634

.123

.012

.479

11.220

.920

.800

2.440

-3.760

-.680

.229

.019

.016

.050

-.077

-.014

50

50

50

50

50

50

Bias

0

.008

.002

-.003

.000

-.025e

SE

0

.148

.142

.127

.101

.036e

1

Sum of Squares and CrossPayment -

Making

(CAH or

Sig. (2-tailed)
products

Root

.091

Pearson Correlation

Funding

Decision

95% Conf.

Lower

1

-.187

-.218

-.051

-.535

-.207e

Interval

Upper

1

.393

.343

.440

-.137

-.080e

Pearson Correlation

.091

1

.172

.084

-.038

.254

Sig. (2-tailed)

.530

.232

.560

.796

.075

Sum of Squares and Cross-

.920

9.120

1.800

.840

-.360

1.520

.019

.186

.037

.017

-.007

.031

products
Covariance

127
n

Bootstrapd

50

50

50

50

50

50

Bias

.008

0

-.002

-.007

.002

.061e

SE

.148

0

.131

.141

.143

.083e

95% Conf.

Lower

-.187

1

-.089

-.235

-.296

.199e

Interval

Upper

.393

1

.421

.333

.263

.505e

Pearson Correlation

.069

.172

1

.315*

-.309*

.117

Sig. (2-tailed)

.634

.232

.026

.029

.420

Sum of Squares and Cross-

.800

1.800

12.000

3.600

-3.400

.800

.016

.037

.245

.073

-.069

.016

50

50

50

50

50

50

Bias

.002

-.002

0

-.008

.004

.028e

SE

.142

.131

0

.140

.142

.039e

products
Dashboard

Covariance
n

Bootstrapd

95% Conf.

Lower

-.218

-.089

1

.015

-.566

.089e

Interval

Upper

.343

.421

1

.566

-.011

.243e

Pearson Correlation

.221

.084

.315*

1

-.145

.098

Sig. (2-tailed)

.123

.560

.026

.315

.498

2.440

.840

3.600

10.880

-1.520

.640

.050

.017

.073

.222

-.031

.013

50

50

50

50

50

50

-.003

-.007

-.008

0

-.001

.024e

.127

.141

.140

0

.147

.034e

Sum of Squares and Crossproducts
Decision

Covariance

making

n
Bias
Bootstrapd

SE
95% Conf.

Lower

-.051

-.235

.015

1

-.435

.071e

Interval

Upper

.440

.333

.566

1

.138

.206e

-.354*

-.038

-.309*

-.145

1

-.089

.012

.796

.029

.315

-3.760

-.360

-3.400

-1.520

10.080

-.560

-.077

-.007

-.069

-.031

.206

-.011

50

50

50

50

50

50

Bias

.000

.002

.004

-.001

0

-.021e

SE

.101

.143

.142

.147

0

.031e

Pearson Correlation
Sig. (2-tailed)
Sum of Squares and Cross-

.538

products
Root Cause

Covariance

for events

n

Bootstrapd

CLABSI

95% Conf.

Lower

-.535

-.296

-.566

-.435

1

-.189e

Interval

Upper

-.137

.263

-.011

.138

1

-.067e

-.103

.254

.117

.098

-.089

1

.479

.075

.420

.498

.538

Pearson Correlation
Sig. (2-tailed)
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Sum of Squares and Cross-

-.680

1.520

.800

.640

-.560

3.920

-.014

.031

.016

.013

-.011

.080

50

50

50

50

50

50

e

e

e

e

e

0e

products
Covariance
n
Bias

-.025

SE

Bootstrapd

.061

.028

.024

-.021

.036e

.083e

.039e

.034e

.031e

0e

95% Conf.

Lower

-.207e

.199e

.089e

.071e

-.189e

1e

Interval

Upper

-.080e

.505e

.243e

.206e

-.067e

1e

*. Correlation is significant at the p < 0.05 level (2-tailed).
d. Unless otherwise noted, bootstrap results are based on 1000 bootstrap samples
e. Based on 636 samples

The following, Table 20, is the output from SPSS for the dependent (criterion
variable) of falls with injury. The information included the details analysis and summary
information can be found in the results section of the chapter.
Table 20
Correlation results for Falls with Injury
Correlations

Funding

Checklist Dashboard

Payment

Decision

Root

Falls

Making

Cause for

with

events

Injury

(CAH or
PPS)
.134

.060

.124

-.377**

.481**

.188

.559

.225

.000

.000

17.061

2.388

1.204

2.286

-7.653

23.551

.176

.025

.012

.024

-.079

.243

98

98

98

98

98

98

Bias

0

.003

.002

-.003

.001

.004

SE

0

.111

.101

.093

.075

.080

1

-.077

-.152

-.072

-.517

.310

1

.361

.255

.297

-.221

.625

Pearson Correlation

.134

1

.164

.215*

-.093

.078

Sig. (2-tailed)

.188

.106

.034

.363

.445

Pearson Correlation

1

Sig. (2-tailed)
Sum of Squares and CrossFunding
Payment (CAH or

products
Covariance
n

PPS)
Bootstrap

c

95%
Conf.
Interval

Checklist

Lower
Upper

129
Sum of Squares and Cross-

2.388

18.622

3.459

4.143

-1.969

3.990

.025

.192

.036

.043

-.020

.041

98

98

98

98

98

98

Bias

.003

0

.001

-.003

.000

-.004

SE

.111

0

.097

.084

.099

.112

-.077

1

-.030

.032

-.287

.361

1

.356

.364

.105

.297

Pearson Correlation

.060

.164

1

.196

-.125

.006

Sig. (2-tailed)

.559

.106

.053

.218

.955

1.204

3.459

23.847

4.286

-3.010

.337

.012

.036

.246

.044

-.031

.003

98

98

98

98

98

98

Bias

.002

.001

0

-.002

.001

-.002

SE

.101

.097

0

.100

.102

.098

-.152

-.030

1

.003

-.328

-.186

.255

.356

1

.386

.069

.186

Pearson Correlation

.124

.215*

.196

1

-.124

.162

Sig. (2-tailed)

.225

.034

.053

.226

.112

2.286

4.143

4.286

20.000

-2.714

8.571

.024

.043

.044

.206

-.028

.088

98

98

98

98

98

98

-.003

-.003

-.002

0

.002

-.002

.093

.084

.100

0

.103

.055

products
Covariance
n

Bootstrap

c

95%
Conf.
Interval

Lower
Upper

Sum of Squares and Crossproducts
Covariance
Dashboard

n

Bootstrap

c

95%
Conf.
Interval

Lower
Upper

Sum of Squares and Crossproducts
Decision
making

Covariance
n
Bias
SE
Bootstrap

c

95%
Conf.
Interval

Pearson Correlation
Sig. (2-tailed)
Root Cause
for events

Sum of Squares and

Lower
Upper

-.072

.032

.003

1

-.313

.036

.297

.364

.386

1

.081

.258

-.377**

-.093

-.125

-.124

1

-.178

.000

.363

.218

.226

-7.653

-1.969

-3.010

-2.714

24.133

-10.378

-.079

-.020

-.031

-.028

.249

-.107

98

98

98

98

98

98

.001

.000

.001

.002

0

.001

.079

Cross-products
Covariance
n
Bootstrap

c

Bias

130
SE
95%

.075

.102

.103

0

.074

-.517

-.287

-.328

-.313

1

-.306

-.221

.105

.069

.081

1

-.005

.481**

.078

.006

.162

-.178

.000

.445

.955

.112

.079

23.551

3.990

.337

8.571

-10.378

140.459

.243

.041

.003

.088

-.107

1.448

98

98

98

98

98

98

Bias

.004

-.004

-.002

-.002

.001

0

SE

.080

.112

.098

.055

.074

0

.310

-.146

-.186

.036

-.306

1

.625

.297

.186

.258

-.005

1

Conf.
Interval

Lower

.099

Upper

Pearson Correlation
Sig. (2-tailed)
Sum of Squares and

1

Cross-products
Falls with

Covariance

injury during n
hospital stay
Bootstrap

c

95%
Conf.
Interval

Lower
Upper

**. Correlation is significant at the p < 0.01 level (2-tailed).
*. Correlation is significant at the p < 0.05 level (2-tailed).
c. Unless otherwise noted, bootstrap results are based on 1000 bootstrap samples

The following, Table 21, is the output from SPSS for the dependent (criterion
variable) of VTE. The information included the details analysis and summary information
can be found in the results section of the chapter.
Table 21
Correlation results for VTE
Correlations

Funding

Checklist Dashboard

Payment

Decision

Root

VTE

Making

Cause for

rates

(CAH or

events

PPS)
Pearson Correlation
Funding

Sig. (2-tailed)

Payment -

Sum of Squares and Cross-

(CAH or

products

PPS)

Covariance
n

.158

.070

.132

-.381**

.523**

.123

.498

.201

.000

.000

16.958

2.729

1.396

2.417

-7.625

26.750

.179

.029

.015

.025

-.080

.282

96

96

96

96

96

96

1
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Bootstrap

c

Bias

0

-.004

.001

-.002

-.003

.018

SE

0

.113

.100

.093

.073

.079

1

-.065

-.133

-.063

-.520

.381

1

.375

.266

.298

-.237

.693

1

.139

.199

-.101

.084

.176

.052

.325

.415

95%
Conf.
Interval

Lower
Upper

Pearson Correlation

.158

Sig. (2-tailed)

.123

Sum of Squares and Cross-

2.729

17.490

2.823

3.708

-2.063

4.375

.029

.184

.030

.039

-.022

.046

96

96

96

96

96

96

-.004

0

-.003

.001

-.002

.017

.113

0

.099

.078

.098

.115

products
Covariance
Checklist

n
Bias
SE
Bootstrapc

95%

Lower

Confiden
ce

-.065

1

-.057

.039

-.291

-.081

.375

1

.333

.349

.091

.364

1

.187

-.130

.156

.068

.207

.130

Upper

Interval
Pearson Correlation

.070

.139

Sig. (2-tailed)

.498

.176

1.396

2.823

23.490

4.042

-3.063

9.375

.015

.030

.247

.043

-.032

.099

96

96

96

96

96

96

Bias

.001

-.003

0

.002

.002

-.001

SE

.100

.099

0

.102

.097

.076

-.133

-.057

1

-.005

-.317

-.011

.266

.333

1

.382

.059

.283

1

-.127

.027

.217

.793

Sum of Squares and Crossproducts
Covariance
Dashboard

n

Bootstrap

c

95%
Conf.
Interval

Lower
Upper

Pearson Correlation

.132

.199

.187

Sig. (2-tailed)

.201

.052

.068

2.417

3.708

4.042

19.833

-2.750

1.500

.025

.039

.043

.209

-.029

.016

96

96

96

96

96

96

-.002

.001

.002

0

.001

.026

.093

.078

.102

0

.105

.130

-.063

.039

-.005

1

-.327

-.185

Sum of Squares and CrossDecision
making

products
Covariance
n
Bias
Bootstrap

c

SE
95%

Lower

132
Conf.

.298

.349

.382

1

.091

.250

-.381**

-.101

-.130

-.127

1

-.244*

.000

.325

.207

.217

-7.625

-2.063

-3.063

-2.750

23.625

-14.750

-.080

-.022

-.032

-.029

.249

-.155

96

96

96

96

96

96

-.003

-.002

.002

.001

0

-.007

.073

.098

.097

.105

0

.047

-.520

-.291

-.317

-.327

1

-.346

-.237

.091

.059

.091

1

-.160

.523**

.084

.156

.027

-.244*

1

.000

.415

.130

.793

.017

26.750

4.375

9.375

1.500

-14.750

154.500

.282

.046

.099

.016

-.155

1.626

96

96

96

96

96

96

Bias

.018

.017

-.001

.026

-.007

0

SE

.079

.115

.076

.130

.047

0

.381

-.081

-.011

-.185

-.346

1

.693

.364

.283

.250

-.160

1

Interval

Upper

Pearson Correlation
Sig. (2-tailed)
Sum of Squares and Cross-

.017

products
Root Cause
for events

Covariance
n
Bias
SE
Bootstrap

c

95%
Conf.
Interval

Lower
Upper

Pearson Correlation
Sig. (2-tailed)
Sum of Squares and Crossproducts
Covariance
VTE rates

n

Bootstrap

c

95%
Conf
Interval

Lower
Upper

**. Correlation is significant at the p < 0.01 level (2-tailed).
*. Correlation is significant at the p < 0.05 level (2-tailed).
c. Unless otherwise noted, bootstrap results are based on 1000 bootstrap samples
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Appendix F: Results of the Variance Inflection Factor – Test for Multicollinearity
The final assumption is for independent errors, which is when two observations
are truly uncorrelated, or indicating no concerns for multicollinearity. The variance
inflation factor (VIF) can be reviewed for multicollinearity, Table 22 below. The variance
inflation factor (VIF) can be reviewed for significance with an average score at or near 1,
and can be tested through the Durbin-Watson test (results from 0-4 with a 2 score are
unrelated; Field, 2013). When the “average VIF is substantially greater than 1 than the
regression may be biased” (Bowerman & O’Connell, 1990, as quoted in Field, 2013).
Table 22
VIF Values (Multicollinearity) and Durbin-Watson (Independent Errors) Results
Dependent Variables
Catheter-Associated Urinary Tract Infection
Central Line-Associated Blood Stream Infections
Injuries and falls from immobility
Venous Thromboembolism

Average VIF
1.12
1.18
1.12
1.12

Durbin-Watson
2.030
2.071
2.361
2.121
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Appendix G: Results for Entire t test for Falls (Funding and Root Cause) and VTE
The following eight tables represent the entire SPSS output for the t test for Falls
and VTE to Funding type and Root Cause Analysis. These tests represent only the
statistically significant results for the t test. Tables 23 to 30 are provided below with
Tables 23 to 26 referring to Falls with Injury and Tables 27 to 30 for VTE results.
Table 23
Group Statistics – Falls to Funding/ Payment Type

Falls with injury
during hospital
stay

Funding Payment System
- Region (CAH or PPS)
Critical Access Hospital
PPS Rural Referral or
Urban

n

M
85
33

SD

.26
1.61

SEM

.639
2.076

.069
.361

Table 24
Independent Samples Test – Falls with Injury to Funding / Payment Type
Levene's Test
for Equality of
Variances
F
Sig.

t

t-test for Equality of Means
df
Sig. Mean Std.
95%
(2Diff Error
Confidence
tailed)
Diff Interval of the
Difference
Lower Upper
116
.000 -1.347 .250 -1.842 -.852

Equal
49.843 .000* -5.391
Falls with variances
injury
assumed
during
Equal
-3.662 34.381
hospital variances
stay
not
assumed
*Statistically Significant to the p < .01 level

.001 -1.347

.368

-2.095

-.600
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Table 25
Group Statistics – Falls with Injury to Root Cause

Falls with injury
during hospital
stay

Root Cause for
events
Yes events
No events

n

M

SD

SEM

56
44

.71
.32

1.461
.708

.195
.107

Table 26
Independent Samples Test – Falls with Injury to Root Cause
Levene's Test
for Equality
of Variances
F
Sig.

t-test for Equality of Means

t

df

Sig. Mean Std.
95%
(2Diff Error Confidence
tailed
Diff Interval of
)
the
Difference
Lowe Upp
r
er
98 .102 .396 .240 -.080 .872

Equal
5.945 .017* 1.651
variances
Falls with
assumed
injury during
Equal
1.780 83.261
hospital stay
variances not
assumed
*Statistically Significant to the p < .05 level

.079

.396

.223 -.046 .839

Table 27
Group Statistics – VTE to Funding
Funding Payment
System - Region
(CAH or PPS)

n

M

SD

SEM

136
Critical Access
Venous
Hospital
Thromboembolism
PPS Rural Referral or
rates
Urban

82

.01

.110

.012

33

1.24

2.000

.348

Table 28
Independent Samples Test – VTE to Funding Payment Type
Levene's Test
for Equality of
Variances
F
Sig.

t-test for Equality of Means

t

df

Sig. (2- Mean Std.
95%
tailed) Diff Error
Confidence
Diff Interval of the
Difference
Lower Upper
113
.000
- .220 -1.667 -.794
1.230

Equal
113.022 .000* -5.584
variances
VTE
assumed
rates
Equal
-3.531 32.079
variances not
assumed
*Statistically Significant to the p < .01 level
Table 29

.001

1.230

.348 -1.940

-.521

Group Statistics – VTE to Root Cause
Root Cause for events
Yes events

Venous
Thromboembolis
No events
m rates

M

n

55
43

.64
.02

SD
1.637
.152

SEM
.221
.023
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Table 30
Independent Samples Test – VTE to Root Cause
Levene's Test
for Equality of
Variances
F
Sig.

t-test for Equality of Means

t

df

Sig. (2- Mean Std.
95%
tailed) Diff Error Confidence
Diff Interval of the
Difference
Lower Upper
96
.016 .613 .251
.115 1.111

Equal
26.725 .000*
2.445
variances
assumed
VTE
Equal
2.762 55.197
rates
variances
not
assumed
*Statistically Significant to the p < .01 level

.008

.613

.222

.168 1.058
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Appendix H: Linear Regression Testing Results for Dependent Variables
The following results in Tables 31 to 32 are from the complete linear regression
analysis for CAUTI, providing the remaining model for the coefficients for the clinical
quality outcomes when analyzing all the predictors as co-variables and the bivariate
correlations between the predictors and criterion.
Table 31
Model 4 Coefficients for predictors of clinical quality outcomes of CAUTI*
b

SE (B)

B

t

Funding Payment

.260
.144
.248
1.811
(-027, .547 )
Leadership Checklist
-.039
.141
-.037
-.290
(-.322, .241)
Incident Dashboard
.014
.128
.040
.308
(-.216, .295)
Board Decision
-.114
.142
-.076
-.596
Making
(-.369, .199)
Root Cause for Events
.118
.138
.071
.511
(-.205, .346)
Note: R2 = .056 for model 4
* With 95% bias corrected and accelerate confidence intervals reported

Coefficients
p
p = .075
p = .773
p= .759
p= .553
p= .611

Table 32
The Bivariate and Partial Correlations of the Predictors with CAUTI
Predictor Variables

Correlation between each
predictor and the criterion
(zero-order)
Funding Payment
.211
Leadership Checklist
-.020*
Incident Dashboard
.031*
Board Decision Making
-.051
Root Cause for Events
-.031*
* Statistically Significant to p < .05

Correlation between each and
criterion for all predictors
(partial)
.226
-.037*
.039*
-.076
.065
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The following results in Tables 33 and 34 are from the complete linear regression
analysis for CLABSI, providing the remaining model for the coefficients for the clinical
quality outcomes when analyzing all the predictors as co-variables and the bivariate
correlations between the predictors and criterion.
Table 33
Model 4 Coefficients for predictors of clinical quality outcomes of CLABSI*
b
Funding Payment

Standard
Error (B)
.092

B

t

-.114
-.194
-1.239
(-.301, .072)
Leadership Checklist
.168
.095
.256
1.764
(-.024, .360)
Incident Dashboard
.009
.091
.016
.100
(-.174, .193)
Board Decision
.057
.092
.095
.621
Making
(-.128, .243)
Root Cause for Events
-.081
.100
-.129
-.807
(-.282, .121)
Note: R2 = .108 for model 4
* With 95% bias corrected and accelerate confidence intervals reported

Coefficients
p
p = .222
p = .085
p= .921
p= .538
p= .424

Table 34
The Bivariate and Partial Correlations of the Predictors with CLABSI
Predictor Variables

Correlation between each
predictor and the criterion
(zero-order)
Funding Payment
-.103
Leadership Checklist
.254
Incident Dashboard
.117
Board Decision Making
.098
Root Cause for Events
-.089
* Statistically Significant to p < .05

Correlation between each and
criterion for all predictors
(partial)
-.184
.257
.015*
.093
-.121

The following results in Tables 35 and 36 are from the complete linear regression
analysis for falls with injuries, providing the remaining model for the coefficients for the
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clinical quality outcomes when analyzing all the predictors as co-variables and the
bivariate correlations between the predictors and criterion.
Table 35
Model Coefficients for predictors of clinical quality outcomes of Falls with Injury*
b
Funding Payment

Standard
Error (B)
.283

B

t

1.358
.473
4.796
(.795, 1.920)
Leadership Checklist
-.005
.259
-.002
-.019
(-.518, .509)
Incident Dashboard
-.105
.227
-.043
-.462
(-.556, .346)
Board Decision
.300
.251
.113
1.194
Making
(-.199, .798)
Root Cause for Events
.021
.238
.009
.087
(-.452, .494)
Note: R2 = .244 for model 4
* With 95% bias corrected and accelerate confidence intervals reported

Coefficients
p
p = .000
p = .985
p= .645
p= .236
p= .931

Table 36
The Bivariate and Partial Correlations of the Predictors with Falls with Injuries
Predictor Variables

Correlation between each
predictor and the criterion
(zero-order)
Funding Payment
.481
Leadership Checklist
.078
Incident Dashboard
.006*
Board Decision Making
.162
Root Cause for Events
-.178
* Statistically Significant to p < .05

Correlation between each and
criterion for all predictors
(partial)
.447
-.002*
-.048*
.124
.009*

The following results in Tables 37 and 38 are from the complete linear regression
analysis for VTE rates, providing the remaining model for the coefficients for the clinical
quality outcomes when analyzing all the predictors as co-variables and the bivariate
correlations between the predictors and criterion.
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Table 37
Model Coefficients for predictors of clinical quality outcomes of VTE*
b
Funding Payment

Standard
Error (B)
.292

B

t

-1.506
.507
5.230
(.949, 2.111)
Leadership Checklist
-.014
.273
-.005
-.052
(-.556, .528)
Incident Dashboard
.328
.234
.128
1.403
(-.137, .793)
Board Decision
-.190
.258
-.068
-.739
Making
(-.702, .321)
Root Cause for Events
-.112
.247
-.044
-.451
(-.603, .380)
Note: R2 = .293 for model 4
* With 95% bias corrected and accelerate confidence intervals reported

Coefficients
p
p = .000
p = .958
p= .164
p= .462
p= .653

Table 38
The Bivariate and Partial Correlations of the Predictors with VTE
Predictor Variables

Correlation between each
predictor and the criterion
(zero-order)
Funding Payment
.532
Leadership Checklist
.084
Incident Dashboard
.156
Board Decision Making
.027*
Root Cause for Events
-.244
*Statistically Significant to p < .05

Correlation between each and
criterion for all predictors
(partial)
.483
-.006*
.146
-.078
-.047*

